CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: geldanamycin
Accession: CHEBI:5292
browse the term
Definition: An ansamycin consisting of a 19-membered macrocyle incorporating a benzoquinone ring and a lactam functionality. It shows antimicrobial activity against many Gram-positive and some Gram-negative bacteria.
Synonyms: exact_synonym: (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate
related_synonym: Formula=C29H40N2O9; InChI=1S/C29H40N2O9/c1-15-11-19-25(34)20(14-21(32)27(19)39-7)31-28(35)16(2)9-8-10-22(37-5)26(40-29(30)36)18(4)13-17(3)24(33)23(12-15)38-6/h8-10,13-15,17,22-24,26,33H,11-12H2,1-7H3,(H2,30,36)(H,31,35)/b10-8-,16-9+,18-13+/t15-,17+,22+,23+,24-,26+/m1/s1; InChIKey=QTQAWLPCGQOSGP-KSRBKZBZSA-N; SMILES=CO[C@H]1C[C@H](C)CC2=C(OC)C(=O)C=C(NC(=O)\\C(C)=C\\C=C/[C@H](OC)[C@@H](OC(N)=O)\\C(C)=C\\[C@H](C)[C@H]1O)C2=O
alt_id: CHEBI:42670
xref: CAS:30562-34-6; KEGG:C11222; KNApSAcK:C00018795
xref_mesh: MESH:C001277
xref: PDBeChem:GDM; PMID:21983172; PMID:21985437; PMID:22050565; PMID:22136518; PMID:22138446; PMID:22215907; PMID:22277058; PMID:22361388; Reaxys:14205884; Wikipedia:Geldanamycin
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions
ISO
geldanamycin inhibits the reaction [TNF protein results in increased expression of ABCB1 mRNA]
CTD
PMID:37586545
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Acap2
ArfGAP with coiled-coil, ankyrin repeat and PH domains 2
increases expression
ISO
geldanamycin results in increased expression of ACAP2 mRNA
CTD
PMID:26705709
NCBI chr11:69,538,487...69,654,156
Ensembl chr11:69,538,546...69,654,151
G
Actr2
actin related protein 2
increases expression
ISO
geldanamycin results in increased expression of ACTR2 mRNA
CTD
PMID:26705709
NCBI chr14:94,296,443...94,333,735
Ensembl chr14:94,296,443...94,340,524
G
Aff3
ALF transcription elongation factor 3
increases expression
ISO
geldanamycin results in increased expression of AFF3 mRNA
CTD
PMID:26705709
NCBI chr 9:40,399,099...40,856,716
Ensembl chr 9:40,404,375...40,857,247
G
Aff4
ALF transcription elongation factor 4
increases expression
ISO
geldanamycin results in increased expression of AFF4 mRNA
CTD
PMID:26705709
NCBI chr10:37,498,825...37,579,751
Ensembl chr10:37,498,825...37,579,751
G
Agfg1
ArfGAP with FG repeats 1
increases expression
ISO
geldanamycin results in increased expression of AGFG1 mRNA
CTD
PMID:26705709
NCBI chr 9:84,124,845...84,182,615
Ensembl chr 9:84,125,120...84,178,128
G
Ahr
aryl hydrocarbon receptor
increases localization decreases expression increases degradation multiple interactions
ISO
geldanamycin results in increased localization of AHR protein geldanamycin results in decreased expression of AHR protein geldanamycin results in increased degradation of AHR protein; geldanamycin results in increased degradation of AHR protein mutant form benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [geldanamycin results in decreased expression of AHR protein] benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [geldanamycin results in increased degradation of AHR protein]; geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [CSK protein binds to AHR protein]]; geldanamycin results in increased localization of and results in increased degradation of AHR protein; lactacystin inhibits the reaction [geldanamycin results in increased degradation of AHR protein]
CTD
PMID:9664232 PMID:12237327 PMID:12606767 PMID:16226227 PMID:20057149 PMID:27105554 More...
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Akt1
AKT serine/threonine kinase 1
multiple interactions decreases phosphorylation decreases expression
ISO
[geldanamycin co-treated with Bortezomib] results in decreased expression of AKT1 protein; geldanamycin inhibits the reaction [Tretinoin results in increased phosphorylation of AKT1 protein]; geldanamycin results in decreased expression of and results in decreased phosphorylation of AKT1 protein geldanamycin results in decreased phosphorylation of AKT1 protein geldanamycin results in decreased expression of AKT1 protein
CTD
PMID:15781649 PMID:17293044 PMID:19167484 PMID:24211270 PMID:24450340
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Akt3
AKT serine/threonine kinase 3
increases expression
ISO
geldanamycin results in increased expression of AKT3 mRNA
CTD
PMID:26705709
NCBI chr13:88,943,708...89,225,831
Ensembl chr13:88,946,091...89,225,708
G
Amotl1
angiomotin-like 1
increases expression
ISO
geldanamycin results in increased expression of AMOTL1 mRNA
CTD
PMID:26705709
NCBI chr 8:11,348,651...11,467,564
Ensembl chr 8:11,353,674...11,467,573
G
Angpt1
angiopoietin 1
increases expression
ISO
geldanamycin results in increased expression of ANGPT1 mRNA
CTD
PMID:26705709
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
G
Angptl1
angiopoietin-like 1
decreases expression
ISO
geldanamycin results in decreased expression of ANGPTL1 mRNA
CTD
PMID:26705709
NCBI chr13:68,963,186...68,981,649
Ensembl chr13:68,962,991...68,992,570
G
Ankrd1
ankyrin repeat domain 1
increases expression
ISO
geldanamycin results in increased expression of ANKRD1 mRNA
CTD
PMID:26705709
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
G
Ap5m1
adaptor related protein complex 5 subunit mu 1
increases expression
ISO
geldanamycin results in increased expression of AP5M1 mRNA
CTD
PMID:26705709
NCBI chr15:22,355,478...22,385,222
Ensembl chr15:22,355,500...22,377,750
G
Apela
apelin receptor early endogenous ligand
increases expression
ISO
geldanamycin results in increased expression of APELA mRNA
CTD
PMID:26705709
NCBI chr16:24,694,356...24,703,466
Ensembl chr16:24,694,324...24,703,465
G
Appl2
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2
increases expression
ISO
geldanamycin results in increased expression of APPL2 mRNA
CTD
PMID:26705709
NCBI chr 7:20,135,248...20,184,757
Ensembl chr 7:20,135,375...20,184,754
G
Arb2a
ARB2 cotranscriptional regulator A
increases expression
ISO
geldanamycin results in increased expression of ARB2A mRNA
CTD
PMID:26705709
NCBI chr 2:7,553,873...8,018,183
Ensembl chr 2:7,553,891...8,018,162
G
Arfip1
ADP-ribosylation factor interacting protein 1
increases expression
ISO
geldanamycin results in increased expression of ARFIP1 mRNA
CTD
PMID:26705709
NCBI chr 2:169,843,804...169,924,136
Ensembl chr 2:169,843,801...169,923,142
G
Aspm
assembly factor for spindle microtubules
increases expression
ISO
geldanamycin results in increased expression of ASPM mRNA
CTD
PMID:26705709
NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755
G
Atp11b
ATPase phospholipid transporting 11B (putative)
increases expression
ISO
geldanamycin results in increased expression of ATP11B mRNA
CTD
PMID:26705709
NCBI chr 2:118,585,348...118,691,076
Ensembl chr 2:118,585,342...118,690,232
G
Atp11c
ATPase phospholipid transporting 11C
increases expression
ISO
geldanamycin results in increased expression of ATP11C mRNA
CTD
PMID:26705709
NCBI chr X:138,564,459...138,752,116
Ensembl chr X:138,565,836...138,751,204
G
Atp13a3
ATPase 13A3
increases expression
ISO
geldanamycin results in increased expression of ATP13A3 mRNA
CTD
PMID:26705709
NCBI chr11:70,364,998...70,442,005
Ensembl chr11:70,365,322...70,441,235
G
Atp13a5
ATPase 13A5
increases expression
ISO
geldanamycin results in increased expression of ATP13A5 mRNA
CTD
PMID:26705709
NCBI chr11:71,376,388...71,515,789
Ensembl chr11:71,376,422...71,515,789
G
Atrx
ATRX, chromatin remodeler
increases expression
ISO
geldanamycin results in increased expression of ATRX mRNA
CTD
PMID:26705709
NCBI chr X:70,850,981...70,997,330
Ensembl chr X:70,850,981...70,997,330
G
Atxn7l3b
ataxin 7-like 3B
increases expression
ISO
geldanamycin results in increased expression of ATXN7L3B mRNA
CTD
PMID:26705709
NCBI chr 7:48,322,451...48,325,975
Ensembl chr 7:48,321,755...48,328,878
G
Bcl2
BCL2, apoptosis regulator
multiple interactions decreases expression
ISO
[geldanamycin co-treated with Bortezomib] results in decreased expression of BCL2 protein; geldanamycin inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA] geldanamycin results in decreased expression of BCL2 protein
CTD
PMID:15781649 PMID:28673683 PMID:37586545
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
decreases response to substance multiple interactions
ISO
BCL2L1 protein results in decreased susceptibility to geldanamycin [geldanamycin co-treated with Bortezomib] results in decreased expression of BCL2L1 protein
CTD
PMID:15781649
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Bcor
BCL6 co-repressor
increases expression
ISO
geldanamycin results in increased expression of BCOR mRNA
CTD
PMID:26705709
NCBI chr X:10,609,756...10,729,613
Ensembl chr X:10,687,732...10,729,613
G
Bdp1
B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB
increases expression
ISO
geldanamycin results in increased expression of BDP1 mRNA
CTD
PMID:26705709
NCBI chr 2:31,378,407...31,470,140
Ensembl chr 2:31,378,924...31,470,119
G
Birc2
baculoviral IAP repeat-containing 2
multiple interactions
ISO
[geldanamycin co-treated with Bortezomib] results in decreased expression of BIRC2 protein
CTD
PMID:15781649
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
G
Bltp2
bridge-like lipid transfer protein family member 2
increases expression
ISO
geldanamycin results in increased expression of BLTP2 mRNA
CTD
PMID:26705709
NCBI chr10:63,155,999...63,185,213
Ensembl chr10:63,156,044...63,191,141
G
Bod1l1
biorientation of chromosomes in cell division 1-like 1
increases expression
ISO
geldanamycin results in increased expression of BOD1L1 mRNA
CTD
PMID:26705709
NCBI chr14:69,108,483...69,163,255
Ensembl chr14:69,108,491...69,162,490
G
C17h5orf24
similar to human chromosome 5 open reading frame 24
increases expression
ISO
geldanamycin results in increased expression of C5ORF24 mRNA
CTD
PMID:26705709
NCBI chr17:8,923,041...8,932,958
Ensembl chr17:8,922,675...8,933,356
G
C2h5orf22
similar to human chromosome 5 open reading frame 22
increases expression
ISO
geldanamycin results in increased expression of C5ORF22 mRNA
CTD
PMID:26705709
NCBI chr 2:61,848,790...61,864,762
Ensembl chr 2:61,849,363...61,864,738
G
Cab39
calcium binding protein 39
increases expression
ISO
geldanamycin results in increased expression of CAB39 mRNA
CTD
PMID:26705709
NCBI chr 9:86,463,095...86,524,545
Ensembl chr 9:86,463,095...86,524,544
G
Cald1
caldesmon 1
increases expression
ISO
geldanamycin results in increased expression of CALD1 mRNA
CTD
PMID:26705709
NCBI chr 4:63,265,781...63,446,938
Ensembl chr 4:63,265,942...63,446,932
G
Cask
calcium/calmodulin dependent serine protein kinase
increases expression
ISO
geldanamycin results in increased expression of CASK mRNA
CTD
PMID:26705709
NCBI chr X:8,899,500...9,243,014
Ensembl chr X:8,899,833...9,238,694
G
Casp3
caspase 3
multiple interactions increases activity
ISO
Acetylcysteine inhibits the reaction [geldanamycin results in increased activity of CASP3 protein]; geldanamycin inhibits the reaction [Demecolcine results in increased activity of CASP3 protein]; geldanamycin inhibits the reaction [Nicotine results in increased activity of CASP3 protein]
CTD
PMID:12115584 PMID:12530016 PMID:14576064 PMID:24998639
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
multiple interactions increases activity
ISO
Acetylcysteine inhibits the reaction [geldanamycin results in increased activity of CASP7 protein]
CTD
PMID:24998639
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp9
caspase 9
multiple interactions
ISO
geldanamycin inhibits the reaction [Doxorubicin results in increased cleavage of CASP9 protein]
CTD
PMID:16311509
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cbl
Cbl proto-oncogene
increases expression
ISO
geldanamycin results in increased expression of CBL mRNA
CTD
PMID:26705709
NCBI chr 8:44,487,824...44,571,620
Ensembl chr 8:44,489,410...44,571,176
G
Ccdc186
coiled-coil domain containing 186
increases expression
ISO
geldanamycin results in increased expression of CCDC186 mRNA
CTD
PMID:26705709
NCBI chr 1:255,831,663...255,871,954
Ensembl chr 1:255,839,595...255,871,935
G
Ccnd1
cyclin D1
multiple interactions decreases expression
ISO
[geldanamycin co-treated with Bortezomib] results in decreased expression of CCND1 protein geldanamycin results in decreased expression of CCND1 mRNA; geldanamycin results in decreased expression of CCND1 protein
CTD
PMID:15781649 PMID:17959518 PMID:24211270
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccnd2
cyclin D2
increases expression
ISO
geldanamycin results in increased expression of CCND2 mRNA
CTD
PMID:26705709
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
G
Ccne2
cyclin E2
increases expression
ISO
geldanamycin results in increased expression of CCNE2 mRNA
CTD
PMID:26705709
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
G
Ccnk
cyclin K
increases expression
ISO
geldanamycin results in increased expression of CCNK mRNA
CTD
PMID:26705709
NCBI chr 6:127,090,115...127,113,195
Ensembl chr 6:127,090,569...127,113,191
G
Cdc27
cell division cycle 27
increases expression
ISO
geldanamycin results in increased expression of CDC27 mRNA
CTD
PMID:26705709
NCBI chr10:89,400,720...89,449,816
Ensembl chr10:89,400,940...89,449,736
G
Cdc37
cell division cycle 37, HSP90 cochaperone
multiple interactions
ISO
geldanamycin inhibits the reaction [HSP90AA1 protein binds to SRC protein binds to CDC37 protein]; geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of CDC37 protein]
CTD
PMID:17223712
NCBI chr 8:19,677,400...19,690,761
Ensembl chr 8:19,671,938...19,690,809
G
Cdca2
cell division cycle associated 2
increases expression
ISO
geldanamycin results in increased expression of CDCA2 mRNA
CTD
PMID:26705709
NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611
G
Cdh1
cadherin 1
multiple interactions increases expression
ISO
geldanamycin promotes the reaction [CDH1 protein binds to CTNNB1 protein]; IL24 protein promotes the reaction [geldanamycin promotes the reaction [CDH1 protein binds to CTNNB1 protein]]; IL24 protein promotes the reaction [geldanamycin results in increased expression of CDH1 protein]
CTD
PMID:17024233
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdh4
cadherin 4
increases expression
ISO
geldanamycin results in increased expression of CDH4 mRNA
CTD
PMID:26705709
NCBI chr 3:166,525,092...167,003,380
Ensembl chr 3:166,525,099...167,003,371
G
Cdk13
cyclin-dependent kinase 13
increases expression
ISO
geldanamycin results in increased expression of CDK13 mRNA
CTD
PMID:26705709
NCBI chr17:47,251,145...47,344,675
Ensembl chr17:47,251,163...47,341,721
G
Cdk14
cyclin-dependent kinase 14
increases expression
ISO
geldanamycin results in increased expression of CDK14 mRNA
CTD
PMID:26705709
NCBI chr 4:28,666,416...29,258,865
Ensembl chr 4:28,666,843...29,258,861
G
Cdk4
cyclin-dependent kinase 4
decreases expression
ISO
geldanamycin results in decreased expression of CDK4 protein
CTD
PMID:28673683
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
G
Cdk6
cyclin-dependent kinase 6
increases expression
ISO
geldanamycin results in increased expression of CDK6 mRNA
CTD
PMID:26705709
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
G
Cebpb
CCAAT/enhancer binding protein beta
multiple interactions
EXP
geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [[CEBPB protein binds to CEBPB protein] which binds to PTGS2 promoter]]
CTD
PMID:11133817
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
G
Cenpj
centromere protein J
increases expression
ISO
geldanamycin results in increased expression of CENPJ mRNA
CTD
PMID:26705709
NCBI chr15:30,627,206...30,690,384
Ensembl chr15:30,627,224...30,686,791
G
Cep89
centrosomal protein 89
increases expression
ISO
geldanamycin results in increased expression of CEP89 mRNA
CTD
PMID:26705709
NCBI chr 1:88,058,211...88,100,114
Ensembl chr 1:88,058,227...88,100,112
G
Cep95
centrosomal protein 95
increases expression
ISO
geldanamycin results in increased expression of CEP95 mRNA
CTD
PMID:26705709
NCBI chr10:91,732,111...91,760,095
Ensembl chr10:91,732,111...91,760,092
G
Cers6
ceramide synthase 6
increases expression
ISO
geldanamycin results in increased expression of CERS6 mRNA
CTD
PMID:26705709
NCBI chr 3:53,630,637...53,879,692
Ensembl chr 3:53,630,959...53,876,848
G
Cftr
CF transmembrane conductance regulator
multiple interactions
ISO
geldanamycin promotes the reaction [5-butyl-7-chloro-6-hydroxybenzo(c)quinolizinium inhibits the reaction [CFTR protein mutant form inhibits the reaction [[Colforsin co-treated with Genistein] results in increased transport of Iodides]]]; geldanamycin promotes the reaction [miglustat inhibits the reaction [CFTR protein mutant form inhibits the reaction [[Colforsin co-treated with Genistein] results in increased transport of Iodides]]]; geldanamycin promotes the reaction [miglustat results in increased activity of CFTR protein mutant form]
CTD
PMID:18230692
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
G
Chuk
component of inhibitor of nuclear factor kappa B kinase complex
increases degradation
ISO
geldanamycin results in increased degradation of CHUK protein
CTD
PMID:15930313
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
G
Clip1
CAP-GLY domain containing linker protein 1
increases expression
ISO
geldanamycin results in increased expression of CLIP1 mRNA
CTD
PMID:26705709
NCBI chr12:32,910,932...33,017,891
Ensembl chr12:32,910,977...33,017,884
G
Clk4
CDC-like kinase 4
increases expression
ISO
geldanamycin results in increased expression of CLK4 mRNA
CTD
PMID:26705709
NCBI chr10:35,523,382...35,541,387
Ensembl chr10:35,524,755...35,541,352
G
Col12a1
collagen type XII alpha 1 chain
increases expression
ISO
geldanamycin results in increased expression of COL12A1 mRNA
CTD
PMID:26705709
NCBI chr 8:80,547,592...80,665,665
Ensembl chr 8:80,547,593...80,665,686
G
Col25a1
collagen type XXV alpha 1 chain
increases expression
ISO
geldanamycin results in increased expression of COL25A1 mRNA
CTD
PMID:26705709
NCBI chr 2:218,755,152...219,154,348
Ensembl chr 2:218,755,691...219,153,501
G
Col8a1
collagen type VIII alpha 1 chain
increases expression
ISO
geldanamycin results in increased expression of COL8A1 mRNA
CTD
PMID:26705709
NCBI chr11:42,776,851...42,906,432
Ensembl chr11:42,777,628...42,906,424
G
Cpne3
copine 3
increases expression
ISO
geldanamycin results in increased expression of CPNE3 mRNA
CTD
PMID:26705709
NCBI chr 5:33,014,658...33,063,934
Ensembl chr 5:33,016,307...33,063,934
G
Crcp
CGRP receptor component
increases expression
ISO
geldanamycin results in increased expression of CRCP mRNA
CTD
PMID:26705709
NCBI chr12:26,623,968...26,659,756
Ensembl chr12:26,623,976...26,768,225
G
Csk
C-terminal Src kinase
multiple interactions decreases activity
ISO
geldanamycin inhibits the reaction [CSK protein results in increased susceptibility to Tetrachlorodibenzodioxin]; geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [CSK protein binds to AHR protein]] geldanamycin results in decreased activity of CSK protein
CTD
PMID:9664232
NCBI chr 8:58,029,748...58,048,742
Ensembl chr 8:58,029,749...58,048,292
G
Csnk2a1
casein kinase 2 alpha 1
increases expression
ISO
geldanamycin results in increased expression of CSNK2A1 mRNA
CTD
PMID:26705709
NCBI chr 3:140,709,984...140,756,757
Ensembl chr 3:140,709,991...140,756,696
G
Ctdspl2
CTD small phosphatase like 2
increases expression
ISO
geldanamycin results in increased expression of CTDSPL2 mRNA
CTD
PMID:26705709
NCBI chr 3:108,915,263...108,970,620
Ensembl chr 3:108,915,280...108,967,227
G
Ctnna1
catenin alpha 1
increases expression
ISO
geldanamycin results in increased expression of CTNNA1 mRNA
CTD
PMID:26705709
NCBI chr18:26,728,246...26,860,911
Ensembl chr18:26,728,485...26,860,910
G
Ctnnb1
catenin beta 1
multiple interactions
ISO
geldanamycin promotes the reaction [CDH1 protein binds to CTNNB1 protein]; IL24 protein promotes the reaction [geldanamycin promotes the reaction [CDH1 protein binds to CTNNB1 protein]]
CTD
PMID:17024233
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Cul5
cullin 5
increases expression
ISO
geldanamycin results in increased expression of CUL5 mRNA
CTD
PMID:26705709
NCBI chr 8:54,012,963...54,066,751
Ensembl chr 8:54,016,006...54,066,666
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
increases expression
ISO
geldanamycin results in increased expression of CYP17A1 mRNA
CTD
PMID:15711029
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
ISO
geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein] geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]
CTD
PMID:12237327 PMID:20057149
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Ddr2
discoidin domain receptor tyrosine kinase 2
increases expression
ISO
geldanamycin results in increased expression of DDR2 mRNA
CTD
PMID:26705709
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
G
Ddx17
DEAD-box helicase 17
increases expression
ISO
geldanamycin results in increased expression of DDX17 mRNA
CTD
PMID:26705709
NCBI chr 7:111,091,127...111,109,353
Ensembl chr 7:111,089,445...111,109,193
G
Ddx3x
DEAD-box helicase 3, X-linked
increases expression increases degradation
ISO
geldanamycin results in increased expression of DDX3X mRNA geldanamycin results in increased degradation of DDX3X protein
CTD
PMID:26705709 PMID:30821613
NCBI chr X:9,479,532...9,493,169
Ensembl chr X:9,479,532...9,493,168
G
Ddx42
DEAD-box helicase 42
increases expression
ISO
geldanamycin results in increased expression of DDX42 mRNA
CTD
PMID:26705709
NCBI chr10:91,148,926...91,180,940
Ensembl chr10:91,148,254...91,180,939
G
Ddx6
DEAD-box helicase 6
increases expression
ISO
geldanamycin results in increased expression of DDX6 mRNA
CTD
PMID:26705709
NCBI chr 8:44,931,127...44,967,773
Ensembl chr 8:44,931,974...44,964,405
G
Dhx9
DExH-box helicase 9
increases expression
ISO
geldanamycin results in increased expression of DHX9 mRNA
CTD
PMID:26705709
NCBI chr13:65,602,322...65,639,098
Ensembl chr13:65,602,323...65,639,069
G
Dip2a
disco-interacting protein 2 homolog A
increases expression
ISO
geldanamycin results in increased expression of DIP2A mRNA
CTD
PMID:26705709
NCBI chr20:12,284,566...12,371,068
Ensembl chr20:12,284,654...12,370,217
G
Dlg1
discs large MAGUK scaffold protein 1
increases expression
ISO
geldanamycin results in increased expression of DLG1 mRNA
CTD
PMID:26705709
NCBI chr11:68,911,883...69,103,230
Ensembl chr11:68,911,883...69,102,689
G
Dmd
dystrophin
increases expression
ISO
geldanamycin results in increased expression of DMD mRNA
CTD
PMID:26705709
NCBI chr X:47,272,324...49,504,219
Ensembl chr X:47,272,331...49,504,207
G
Dnajc13
DnaJ heat shock protein family (Hsp40) member C13
increases expression
ISO
geldanamycin results in increased expression of DNAJC13 mRNA
CTD
PMID:26705709
NCBI chr 8:104,767,785...104,877,317
Ensembl chr 8:104,767,788...104,877,317
G
Dst
dystonin
increases expression
ISO
geldanamycin results in increased expression of DST mRNA
CTD
PMID:26705709
NCBI chr 9:36,135,657...36,529,617
Ensembl chr 9:36,135,284...36,529,615
G
E2f3
E2F transcription factor 3
increases expression
ISO
geldanamycin results in increased expression of E2F3 mRNA
CTD
PMID:26705709
NCBI chr17:34,601,756...34,679,139
Ensembl chr17:34,601,830...34,676,253
G
Edil3
EGF like repeats and discoidin domains 3
increases expression
ISO
geldanamycin results in increased expression of EDIL3 mRNA
CTD
PMID:26705709
NCBI chr 2:19,890,396...20,405,028
Ensembl chr 2:19,890,373...20,405,008
G
Edn1
endothelin 1
increases expression
ISO
geldanamycin results in increased expression of EDN1 mRNA
CTD
PMID:26705709
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Eea1
early endosome antigen 1
increases expression
ISO
geldanamycin results in increased expression of EEA1 mRNA
CTD
PMID:26705709
NCBI chr 7:30,554,686...30,722,186
Ensembl chr 7:30,554,552...30,718,487
G
Egf
epidermal growth factor
multiple interactions
EXP ISO
geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [EGF protein binds to EGFR protein]]
CTD
PMID:9605431 PMID:9664232
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
G
Egfr
epidermal growth factor receptor
multiple interactions decreases expression
ISO EXP
geldanamycin inhibits the reaction [TNF protein results in increased expression of EGFR mRNA]; geldanamycin promotes the reaction [Sulfasalazine results in decreased expression of EGFR protein] geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [EGF protein binds to EGFR protein]] geldanamycin results in decreased expression of EGFR protein
CTD
PMID:9605431 PMID:9664232 PMID:20007406 PMID:37586545
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Ehbp1
EH domain binding protein 1
increases expression
ISO
geldanamycin results in increased expression of EHBP1 mRNA
CTD
PMID:26705709
NCBI chr14:96,093,327...96,380,502
Ensembl chr14:96,093,327...96,345,332
G
Ehmt1
euchromatic histone lysine methyltransferase 1
increases expression
ISO
geldanamycin results in increased expression of EHMT1 mRNA
CTD
PMID:26705709
NCBI chr 3:7,580,680...7,729,046
Ensembl chr 3:7,580,683...7,729,007
G
Eif4a1
eukaryotic translation initiation factor 4A1
increases degradation
ISO
geldanamycin results in increased degradation of EIF4A1 protein
CTD
PMID:30821613
NCBI chr10:54,384,345...54,389,855
Ensembl chr10:54,384,347...54,389,858
G
Ell2
elongation factor for RNA polymerase II 2
increases expression
ISO
geldanamycin results in increased expression of ELL2 mRNA
CTD
PMID:26705709
NCBI chr 2:5,189,375...5,258,781
Ensembl chr 2:5,189,971...5,258,781
G
Epb41l5
erythrocyte membrane protein band 4.1 like 5
increases expression
ISO
geldanamycin results in increased expression of EPB41L5 mRNA
CTD
PMID:26705709
NCBI chr13:30,670,792...30,770,213
Ensembl chr13:30,669,764...30,768,360
G
Eprs1
glutamyl-prolyl-tRNA synthetase 1
increases expression
ISO
geldanamycin results in increased expression of EPRS1 mRNA
CTD
PMID:26705709
NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966
G
Erbb2
erb-b2 receptor tyrosine kinase 2
increases degradation multiple interactions decreases expression
ISO
geldanamycin results in increased degradation of ERBB2 protein [geldanamycin binds to HSP90B1 protein] inhibits the reaction [HSP90B1 protein binds to ERBB2 protein]; geldanamycin inhibits the reaction [Quercetin promotes the reaction [ERBB2 protein binds to HSP90AA1 protein]]; geldanamycin results in decreased expression of and results in increased ubiquitination of ERBB2 protein; Quercetin promotes the reaction [geldanamycin results in decreased expression of and results in increased ubiquitination of ERBB2 protein] geldanamycin results in decreased expression of ERBB2 protein
CTD
PMID:8617772 PMID:11071886 PMID:17959518 PMID:18655187 PMID:24450340
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
G
Ercc6l2
ERCC excision repair 6 like 2
increases expression
ISO
geldanamycin results in increased expression of ERCC6L2 mRNA
CTD
PMID:26705709
NCBI chr17:1,076,486...1,311,281
Ensembl chr17:1,216,428...1,310,275
G
Esco1
establishment of sister chromatid cohesion N-acetyltransferase 1
increases expression
ISO
geldanamycin results in increased expression of ESCO1 mRNA
CTD
PMID:26705709
NCBI chr18:1,630,560...1,686,803
Ensembl chr18:1,631,954...1,686,942
G
Esco2
establishment of sister chromatid cohesion N-acetyltransferase 2
increases expression
ISO
geldanamycin results in increased expression of ESCO2 mRNA
CTD
PMID:26705709
NCBI chr15:40,034,566...40,052,295
Ensembl chr15:40,034,568...40,055,306
G
Esr1
estrogen receptor 1
multiple interactions decreases expression decreases stability increases degradation
ISO
geldanamycin inhibits the reaction [Estradiol binds to ESR1 protein]; geldanamycin promotes the reaction [ESR1 protein binds to STUB1 protein]; STUB1 protein promotes the reaction [geldanamycin results in increased degradation of ESR1 protein] geldanamycin results in decreased expression of ESR1 protein geldanamycin results in decreased stability of ESR1 protein
CTD
PMID:11448926 PMID:16037132 PMID:24211270
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Ets1
ETS proto-oncogene 1, transcription factor
increases expression
ISO
geldanamycin results in increased expression of ETS1 mRNA
CTD
PMID:26705709
NCBI chr 8:31,045,909...31,168,010
Ensembl chr 8:31,045,945...31,168,010
G
Evi5
ecotropic viral integration site 5
increases expression
ISO
geldanamycin results in increased expression of EVI5 mRNA
CTD
PMID:26705709
NCBI chr14:1,875,601...2,021,678
Ensembl chr14:1,875,647...2,021,678
G
Fancb
FA complementation group B
increases expression
ISO
geldanamycin results in increased expression of FANCB mRNA
CTD
PMID:26705709
NCBI chr X:29,403,771...29,420,484
Ensembl chr X:29,403,771...29,420,192
G
Fancm
FA complementation group M
increases expression
ISO
geldanamycin results in increased expression of FANCM mRNA
CTD
PMID:26705709
NCBI chr 6:83,126,903...83,180,455
Ensembl chr 6:83,127,093...83,180,028
G
Fbn1
fibrillin 1
increases expression
ISO
geldanamycin results in increased expression of FBN1 mRNA
CTD
PMID:26705709
NCBI chr 3:112,554,257...112,750,835
Ensembl chr 3:112,554,925...112,750,889
G
Fgf7
fibroblast growth factor 7
multiple interactions
ISO
geldanamycin inhibits the reaction [ammonium trichloro(dioxoethylene-O,O'-)tellurate results in increased expression of FGF7 protein]
CTD
PMID:14656992
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
G
Flt1
Fms related receptor tyrosine kinase 1
increases expression
ISO
geldanamycin results in increased expression of FLT1 mRNA
CTD
PMID:26705709
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
G
Fn1
fibronectin 1
increases expression
ISO
geldanamycin results in increased expression of FN1 mRNA
CTD
PMID:26705709
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Fryl
FRY like transcription coactivator
increases expression
ISO
geldanamycin results in increased expression of FRYL mRNA
CTD
PMID:26705709
NCBI chr14:34,956,623...35,189,738
Ensembl chr14:34,956,620...35,190,222
G
G3bp1
G3BP stress granule assembly factor 1
increases expression
ISO
geldanamycin results in increased expression of G3BP1 mRNA
CTD
PMID:26705709
NCBI chr10:39,586,864...39,620,268
Ensembl chr10:39,586,864...39,620,268
G
Galnt5
polypeptide N-acetylgalactosaminyltransferase 5
increases expression
ISO
geldanamycin results in increased expression of GALNT5 mRNA
CTD
PMID:26705709
NCBI chr 3:42,573,622...42,619,881
Ensembl chr 3:42,573,622...42,619,881
G
Gls
glutaminase
increases expression
ISO
geldanamycin results in increased expression of GLS mRNA
CTD
PMID:26705709
NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900
G
Gng12
G protein subunit gamma 12
increases expression
ISO
geldanamycin results in increased expression of GNG12 mRNA
CTD
PMID:26705709
NCBI chr 4:96,011,118...96,134,767
Ensembl chr 4:96,010,952...96,134,712
G
Golim4
golgi integral membrane protein 4
increases expression
ISO
geldanamycin results in increased expression of GOLIM4 mRNA
CTD
PMID:26705709
NCBI chr 2:160,640,837...160,733,475
Ensembl chr 2:160,640,938...160,733,253
G
Gria3
glutamate ionotropic receptor AMPA type subunit 3
increases expression
ISO
geldanamycin results in increased expression of GRIA3 mRNA
CTD
PMID:26705709
NCBI chr X:120,238,515...120,504,106
Ensembl chr X:120,238,534...120,504,096
G
Gtf2a1
general transcription factor 2A subunit 1
increases expression
ISO
geldanamycin results in increased expression of GTF2A1 mRNA
CTD
PMID:26705709
NCBI chr 6:110,488,891...110,521,502
Ensembl chr 6:110,488,931...110,521,511
G
H4f3
H1.3 linker histone, cluster member
increases expression
ISO
geldanamycin results in increased expression of H1-3 mRNA
CTD
PMID:26705709
NCBI chr17:41,551,524...41,552,303
Ensembl chr17:41,529,667...41,552,334
G
Hacd2
3-hydroxyacyl-CoA dehydratase 2
increases expression
ISO
geldanamycin results in increased expression of HACD2 mRNA
CTD
PMID:26705709
NCBI chr11:65,667,671...65,762,903
Ensembl chr11:65,670,281...65,762,889
G
Hcn1
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1
increases expression
ISO
geldanamycin results in increased expression of HCN1 mRNA
CTD
PMID:26705709
NCBI chr 2:49,495,771...49,899,983
Ensembl chr 2:49,495,771...49,899,774
G
Heatr1
HEAT repeat containing 1
increases expression
ISO
geldanamycin results in increased expression of HEATR1 mRNA
CTD
PMID:26705709
NCBI chr17:58,053,288...58,093,895
Ensembl chr17:58,051,700...58,093,948
G
Hectd1
HECT domain E3 ubiquitin protein ligase 1
increases expression
ISO
geldanamycin results in increased expression of HECTD1 mRNA
CTD
PMID:26705709
NCBI chr 6:69,181,429...69,268,045
Ensembl chr 6:69,181,436...69,268,053
G
Hif1a
hypoxia inducible factor 1 subunit alpha
multiple interactions decreases expression increases degradation
ISO
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [geldanamycin results in increased degradation of HIF1A protein]; geldanamycin inhibits the reaction [cobaltous chloride results in increased expression of HIF1A protein]; geldanamycin inhibits the reaction [TNF protein results in increased expression of HIF1A mRNA]; lactacystin inhibits the reaction [geldanamycin results in increased degradation of HIF1A protein] geldanamycin results in decreased expression of HIF1A protein
CTD
PMID:11980636 PMID:12811834 PMID:14726529 PMID:15319539 PMID:16432534 PMID:37586545 More...
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
geldanamycin inhibits the reaction [solanesol results in increased expression of HMOX1 mRNA]; geldanamycin inhibits the reaction [solanesol results in increased expression of HMOX1 protein]
CTD
PMID:25645596
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hpgd
15-hydroxyprostaglandin dehydrogenase
multiple interactions
ISO
geldanamycin inhibits the reaction [Dexamethasone results in increased expression of and results in increased activity of HPGD protein]
CTD
PMID:15680906
NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228
G
Hsf1
heat shock transcription factor 1
multiple interactions
ISO
geldanamycin inhibits the reaction [solanesol promotes the reaction [HSF1 protein binds to STUB1 protein]]; geldanamycin results in increased phosphorylation of and results in increased activity of HSF1 protein
CTD
PMID:10632574 PMID:25645596
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
affects binding multiple interactions
EXP ISO
geldanamycin binds to HSP90AA1 protein geldanamycin inhibits the reaction [HSP90AA1 protein binds to SRC protein binds to CDC37 protein]; geldanamycin inhibits the reaction [KCNH2 protein binds to HSP90AA1 protein]; geldanamycin inhibits the reaction [Quercetin promotes the reaction [ERBB2 protein binds to HSP90AA1 protein]]
CTD
PMID:12775586 PMID:17223712 PMID:18655187 PMID:21749116
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
G
Hsp90ab1
heat shock protein 90 alpha family class B member 1
affects binding increases expression
EXP ISO
geldanamycin binds to HSP90AB1 protein geldanamycin results in increased expression of HSP90AB1 mRNA
CTD
PMID:21749116 PMID:26705709
NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
G
Hsp90b1
heat shock protein 90 beta family member 1
affects binding multiple interactions
ISO
geldanamycin binds to HSP90B1 protein [geldanamycin binds to HSP90B1 protein] inhibits the reaction [HSP90B1 protein binds to ERBB2 protein]
CTD
PMID:8617772
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
increases expression multiple interactions
EXP ISO
geldanamycin results in increased expression of HSPA1A mRNA; geldanamycin results in increased expression of HSPA1A protein [geldanamycin results in increased expression of HSPA1A protein] which results in decreased susceptibility to Gentamicins
CTD
PMID:11448926 PMID:19723345 PMID:25477506
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa4
heat shock protein family A (Hsp70) member 4
increases expression multiple interactions
ISO
geldanamycin results in increased expression of HSPA4 mRNA; geldanamycin results in increased expression of HSPA4 protein [geldanamycin results in increased expression of HSPA4 protein] which results in decreased susceptibility to Doxorubicin
CTD
PMID:16311509 PMID:26705709
NCBI chr10:37,408,025...37,449,080
Ensembl chr10:37,408,025...37,449,001
G
Hspa5
heat shock protein family A (Hsp70) member 5
multiple interactions increases expression affects expression
ISO
Bortezomib promotes the reaction [geldanamycin results in increased expression of HSPA5 protein]; geldanamycin promotes the reaction [Bortezomib results in increased expression of HSPA5 protein] geldanamycin affects the expression of HSPA5 protein
CTD
PMID:14576064 PMID:15141013
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hspd1
heat shock protein family D (Hsp60) member 1
increases expression
ISO
geldanamycin results in increased expression of HSPD1 mRNA
CTD
PMID:26705709
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
G
Htt
huntingtin
multiple interactions
ISO
geldanamycin inhibits the reaction [HTT protein binds to HTT protein]
CTD
PMID:11406612
NCBI chr14:75,845,836...75,996,094
Ensembl chr14:75,845,836...75,995,070
G
Hycc1
hyccin PI4KA lipid kinase complex subunit 1
increases expression
ISO
geldanamycin results in increased expression of HYCC1 mRNA
CTD
PMID:26705709
NCBI chr 4:11,132,224...11,239,120
Ensembl chr 4:11,132,385...11,239,113
G
Ice2
interactor of little elongation complex ELL subunit 2
increases expression
ISO
geldanamycin results in increased expression of ICE2 mRNA
CTD
PMID:26705709
NCBI chr 8:70,043,419...70,085,217
Ensembl chr 8:70,043,424...70,084,995
G
Il1b
interleukin 1 beta
multiple interactions
ISO EXP
geldanamycin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL1B mRNA] geldanamycin inhibits the reaction [TNF protein results in increased expression of IL1B mRNA] geldanamycin inhibits the reaction [IL1B protein results in decreased expression of VLDLR protein]
CTD
PMID:12571865 PMID:15808840 PMID:37586545
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il24
interleukin 24
multiple interactions
ISO
IL24 protein promotes the reaction [geldanamycin promotes the reaction [CDH1 protein binds to CTNNB1 protein]]; IL24 protein promotes the reaction [geldanamycin results in increased expression of CDH1 protein]
CTD
PMID:17024233
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
G
Il6
interleukin 6
multiple interactions
ISO
geldanamycin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 mRNA]
CTD
PMID:12571865
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il6st
interleukin 6 cytokine family signal transducer
increases expression
ISO
geldanamycin results in increased expression of IL6ST mRNA
CTD
PMID:26705709
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
G
Inhba
inhibin subunit beta A
increases expression
ISO
geldanamycin results in increased expression of INHBA mRNA
CTD
PMID:26705709
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
G
Inpp5a
inositol polyphosphate-5-phosphatase A
increases expression
ISO
geldanamycin results in increased expression of INPP5A mRNA
CTD
PMID:26705709
NCBI chr 1:194,190,086...194,380,429
Ensembl chr 1:194,190,393...194,380,428
G
Ipo8
importin 8
increases expression
ISO
geldanamycin results in increased expression of IPO8 mRNA
CTD
PMID:26705709
NCBI chr 4:181,729,216...181,793,672
Ensembl chr 4:181,729,220...181,793,161
G
Iqgap1
IQ motif containing GTPase activating protein 1
increases expression
ISO
geldanamycin results in increased expression of IQGAP1 mRNA
CTD
PMID:26705709
NCBI chr 1:134,679,581...134,769,776
Ensembl chr 1:134,679,586...134,769,755
G
Itga1
integrin subunit alpha 1
increases expression
ISO
geldanamycin results in increased expression of ITGA1 mRNA
CTD
PMID:26705709
NCBI chr 2:46,646,125...46,812,237
Ensembl chr 2:46,653,193...46,812,238
G
Itgb3
integrin subunit beta 3
increases expression
ISO
geldanamycin results in increased expression of ITGB3 mRNA
CTD
PMID:26705709
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
G
Itprid2
ITPR interacting domain containing 2
increases expression
ISO
geldanamycin results in increased expression of SSFA2 mRNA
CTD
PMID:26705709
NCBI chr 3:64,536,707...64,573,978
Ensembl chr 3:64,536,707...64,573,978
G
Jmjd1c
jumonji domain containing 1C
increases expression
ISO
geldanamycin results in increased expression of JMJD1C mRNA
CTD
PMID:26705709
NCBI chr20:21,332,147...21,494,220
Ensembl chr20:21,332,147...21,463,122
G
Kat6a
lysine acetyltransferase 6A
increases expression
ISO
geldanamycin results in increased expression of KAT6A mRNA
CTD
PMID:26705709
NCBI chr16:69,084,914...69,165,923
Ensembl chr16:69,084,914...69,163,606
G
Kbtbd2
kelch repeat and BTB domain containing 2
increases expression
ISO
geldanamycin results in increased expression of KBTBD2 mRNA
CTD
PMID:26705709
NCBI chr 4:86,027,947...86,050,266
Ensembl chr 4:86,027,947...86,050,211
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
affects localization decreases activity increases degradation multiple interactions decreases expression
ISO
geldanamycin affects the localization of KCNH2 protein geldanamycin results in decreased activity of KCNH2 protein geldanamycin results in increased degradation of KCNH2 protein geldanamycin inhibits the reaction [KCNH2 protein binds to HSP90AA1 protein] geldanamycin results in decreased expression of KCNH2 protein modified form
CTD
PMID:12775586 PMID:24052561
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Kdm6a
lysine demethylase 6A
increases expression
ISO
geldanamycin results in increased expression of KDM6A mRNA
CTD
PMID:26705709
NCBI chr X:4,337,466...4,477,100
Ensembl chr X:4,337,750...4,477,062
G
Kirrel1
kirre like nephrin family adhesion molecule 1
increases expression
ISO
geldanamycin results in increased expression of KIRREL1 mRNA
CTD
PMID:26705709
NCBI chr 2:172,521,644...172,615,057
Ensembl chr 2:172,525,245...172,615,299
G
Klf12
KLF transcription factor 12
increases expression
ISO
geldanamycin results in increased expression of KLF12 mRNA
CTD
PMID:26705709
NCBI chr15:76,628,778...77,062,000
Ensembl chr15:76,637,654...77,062,056
G
Klhl24
kelch-like family member 24
increases expression
ISO
geldanamycin results in increased expression of KLHL24 mRNA
CTD
PMID:26705709
NCBI chr11:80,843,621...80,877,649
Ensembl chr11:80,846,755...80,877,636
G
Kmt2a
lysine methyltransferase 2A
increases expression
ISO
geldanamycin results in increased expression of KMT2A mRNA
CTD
PMID:26705709
NCBI chr 8:45,116,763...45,193,320
Ensembl chr 8:45,118,814...45,193,181
G
Knl1
kinetochore scaffold 1
increases expression
ISO
geldanamycin results in increased expression of KNL1 mRNA
CTD
PMID:26705709
NCBI chr 3:106,029,627...106,091,915
Ensembl chr 3:106,029,661...106,091,915
G
Lama4
laminin subunit alpha 4
increases expression
ISO
geldanamycin results in increased expression of LAMA4 mRNA
CTD
PMID:26705709
NCBI chr20:42,392,268...42,533,347
Ensembl chr20:42,392,268...42,533,347
G
Larp1b
La ribonucleoprotein 1B
increases expression
ISO
geldanamycin results in increased expression of LARP1B mRNA
CTD
PMID:26705709
NCBI chr 2:123,936,057...123,969,254
Ensembl chr 2:123,935,983...123,968,896
G
Larp4
La ribonucleoprotein 4
increases expression
ISO
geldanamycin results in increased expression of LARP4 mRNA
CTD
PMID:26705709
NCBI chr 7:131,104,470...131,152,692
Ensembl chr 7:131,101,564...131,150,811
G
Lars1
leucyl-tRNA synthetase 1
increases expression
ISO
geldanamycin results in increased expression of LARS1 mRNA
CTD
PMID:26705709
NCBI chr18:34,201,555...34,256,003
Ensembl chr18:34,201,549...34,255,931
G
Lima1
LIM domain and actin binding 1
increases expression
ISO
geldanamycin results in increased expression of LIMA1 mRNA
CTD
PMID:26705709
NCBI chr 7:130,901,717...131,001,512
Ensembl chr 7:130,901,717...131,001,473
G
Lin7a
lin-7 homolog A, crumbs cell polarity complex component
increases expression
ISO
geldanamycin results in increased expression of LIN7A mRNA
CTD
PMID:26705709
NCBI chr 7:42,586,704...42,742,609
Ensembl chr 7:42,586,719...42,730,550
G
Lman1
lectin, mannose-binding, 1
increases expression
ISO
geldanamycin results in increased expression of LMAN1 mRNA
CTD
PMID:26705709
NCBI chr18:59,508,996...59,530,873
Ensembl chr18:59,508,996...59,530,851
G
Lmo7
LIM domain 7
increases expression
ISO
geldanamycin results in increased expression of LMO7 mRNA
CTD
PMID:26705709
NCBI chr15:78,566,999...78,769,833
Ensembl chr15:78,567,023...78,769,783
G
Lpp
LIM domain containing preferred translocation partner in lipoma
increases expression
ISO
geldanamycin results in increased expression of LPP mRNA
CTD
PMID:26705709
NCBI chr11:75,787,326...76,426,646
Ensembl chr11:75,797,078...76,422,597
G
Lrrc58
leucine rich repeat containing 58
increases expression
ISO
geldanamycin results in increased expression of LRRC58 mRNA
CTD
PMID:26705709
NCBI chr11:62,850,507...62,862,829
Ensembl chr11:62,847,562...62,862,829
G
Lsm14b
LSM family member 14B
increases expression
ISO
geldanamycin results in increased expression of LSM14B mRNA
CTD
PMID:26705709
NCBI chr 3:167,125,633...167,136,417
Ensembl chr 3:167,125,628...167,136,432
G
Man1a2
mannosidase, alpha, class 1A, member 2
increases expression
ISO
geldanamycin results in increased expression of MAN1A2 mRNA
CTD
PMID:26705709
NCBI chr 2:187,947,484...188,096,332
Ensembl chr 2:187,951,617...188,096,332
G
Map1b
microtubule-associated protein 1B
increases expression
ISO
geldanamycin results in increased expression of MAP1B mRNA
CTD
PMID:26705709
NCBI chr 2:30,817,261...30,910,458
Ensembl chr 2:30,817,261...30,910,317
G
Map2k1
mitogen activated protein kinase kinase 1
multiple interactions decreases phosphorylation
ISO
geldanamycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MAP2K1 protein] geldanamycin results in decreased phosphorylation of MAP2K1 protein
CTD
PMID:8816498 PMID:19167484
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
G
Map2k2
mitogen activated protein kinase kinase 2
decreases phosphorylation
ISO
geldanamycin results in decreased phosphorylation of MAP2K2 protein
CTD
PMID:19167484
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
G
Map3k1
mitogen-activated protein kinase kinase kinase 1
increases expression
ISO
geldanamycin results in increased expression of MAP3K1 mRNA
CTD
PMID:26705709
NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:43,350,098...43,414,463
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
increases expression
ISO
geldanamycin results in increased expression of MAP3K5 mRNA
CTD
PMID:26705709
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
G
Map4k5
mitogen-activated protein kinase kinase kinase kinase 5
increases expression
ISO
geldanamycin results in increased expression of MAP4K5 mRNA
CTD
PMID:26705709
NCBI chr 6:88,284,087...88,377,118
Ensembl chr 6:88,284,094...88,376,799
G
Mapk1
mitogen activated protein kinase 1
multiple interactions decreases expression decreases phosphorylation
ISO
geldanamycin inhibits the reaction [Dieldrin results in increased phosphorylation of MAPK1 protein]; geldanamycin inhibits the reaction [Endosulfan results in increased phosphorylation of MAPK1 protein]; geldanamycin inhibits the reaction [Heptachlor results in increased phosphorylation of MAPK1 protein]; geldanamycin inhibits the reaction [Hexachlorocyclohexane results in increased phosphorylation of MAPK1 protein]; geldanamycin inhibits the reaction [Tretinoin results in increased phosphorylation of MAPK1 protein] geldanamycin results in decreased expression of MAPK1 mRNA geldanamycin results in decreased phosphorylation of MAPK1 protein geldanamycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein]
CTD
PMID:8816498 PMID:15888667 PMID:17293044 PMID:19167484 PMID:30166341
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions decreases phosphorylation
ISO
geldanamycin inhibits the reaction [Dieldrin results in increased phosphorylation of MAPK3 protein]; geldanamycin inhibits the reaction [Endosulfan results in increased phosphorylation of MAPK3 protein]; geldanamycin inhibits the reaction [Heptachlor results in increased phosphorylation of MAPK3 protein]; geldanamycin inhibits the reaction [Hexachlorocyclohexane results in increased phosphorylation of MAPK3 protein]; geldanamycin inhibits the reaction [Tretinoin results in increased phosphorylation of MAPK3 protein] geldanamycin results in decreased phosphorylation of MAPK3 protein geldanamycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein]
CTD
PMID:8816498 PMID:15888667 PMID:17293044 PMID:19167484
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapkapk2
MAPK activated protein kinase 2
increases expression
ISO
geldanamycin results in increased expression of MAPKAPK2 mRNA
CTD
PMID:26705709
NCBI chr13:42,513,762...42,560,061
Ensembl chr13:42,513,762...42,560,457
G
Matr3
matrin 3
increases expression
ISO
geldanamycin results in increased expression of MATR3 mRNA
CTD
PMID:26705709
NCBI chr18:27,154,098...27,193,212
Ensembl chr18:27,163,714...27,193,166
G
Mbnl1
muscleblind-like splicing regulator 1
increases expression
ISO
geldanamycin results in increased expression of MBNL1 mRNA
CTD
PMID:26705709
NCBI chr 2:144,639,819...144,814,395
Ensembl chr 2:144,670,285...144,814,368
G
Mbnl2
muscleblind-like splicing regulator 2
increases expression
ISO
geldanamycin results in increased expression of MBNL2 mRNA
CTD
PMID:26705709
NCBI chr15:97,385,278...97,542,924
Ensembl chr15:97,385,244...97,542,937
G
Mbtd1
mbt domain containing 1
increases expression
ISO
geldanamycin results in increased expression of MBTD1 mRNA
CTD
PMID:26705709
NCBI chr10:78,839,140...78,895,413
Ensembl chr10:78,839,036...78,893,720
G
Mcam
melanoma cell adhesion molecule
increases expression
ISO
geldanamycin results in increased expression of MCAM mRNA
CTD
PMID:26705709
NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571
G
Mcm4
minichromosome maintenance complex component 4
increases expression
ISO
geldanamycin results in increased expression of MCM4 mRNA
CTD
PMID:26705709
NCBI chr11:85,258,443...85,272,144
Ensembl chr11:85,258,443...85,272,144
G
Mdfic
MyoD family inhibitor domain containing
increases expression
ISO
geldanamycin results in increased expression of MDFIC mRNA
CTD
PMID:26705709
NCBI chr 4:43,972,310...44,052,162
Ensembl chr 4:43,972,507...44,052,161
G
Mdm2
MDM2 proto-oncogene
increases expression
ISO
geldanamycin results in increased expression of MDM2 mRNA
CTD
PMID:26705709
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Med13
mediator complex subunit 13
increases expression
ISO
geldanamycin results in increased expression of MED13 mRNA
CTD
PMID:26705709
NCBI chr10:71,086,978...71,176,535
Ensembl chr10:71,090,516...71,177,242
G
Med7
mediator complex subunit 7
increases expression
ISO
geldanamycin results in increased expression of MED7 mRNA
CTD
PMID:26705709
NCBI chr10:30,842,330...30,857,873
Ensembl chr10:30,842,292...30,859,220
G
Met
MET proto-oncogene, receptor tyrosine kinase
increases expression
ISO
geldanamycin results in increased expression of MET mRNA
CTD
PMID:26705709
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Mettl16
methyltransferase 16, RNA N6-adenosine
increases expression
ISO
geldanamycin results in increased expression of METTL16 mRNA
CTD
PMID:26705709
NCBI chr10:59,640,915...59,697,291
Ensembl chr10:59,640,972...59,687,061
G
Mgmt
O-6-methylguanine-DNA methyltransferase
multiple interactions
ISO
geldanamycin results in increased expression of and results in increased activity of MGMT protein
CTD
PMID:16950796
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
G
Mier1
MIER1 transcriptional regulator
increases expression
ISO
geldanamycin results in increased expression of MIER1 mRNA
CTD
PMID:26705709
NCBI chr 5:117,876,012...117,927,592
Ensembl chr 5:117,870,382...117,927,589
G
Mir21
microRNA 21
increases expression
ISO
geldanamycin results in increased expression of MIR21 mRNA
CTD
PMID:26705709
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
G
Mis18bp1
MIS18 binding protein 1
increases expression
ISO
geldanamycin results in increased expression of MIS18BP1 mRNA
CTD
PMID:26705709
NCBI chr 6:83,182,497...83,231,978
Ensembl chr 6:83,182,499...83,231,383
G
Mmp1
matrix metallopeptidase 1
multiple interactions decreases expression
ISO
[geldanamycin co-treated with PTHLH protein modified form] results in increased expression of MMP1 mRNA geldanamycin results in decreased expression of MMP1 mRNA
CTD
PMID:12724357 PMID:26705709
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mmp16
matrix metallopeptidase 16
increases expression
ISO
geldanamycin results in increased expression of MMP16 mRNA
CTD
PMID:26705709
NCBI chr 5:31,312,280...31,556,276
Ensembl chr 5:31,312,280...31,548,388
G
Mt-nd6
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6
increases expression
ISO
geldanamycin results in increased expression of ND6 mRNA
CTD
PMID:26705709
NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061
Ensembl chr MT:13,543...14,061
G
Myo5a
myosin VA
increases expression
ISO
geldanamycin results in increased expression of MYO5A mRNA
CTD
PMID:26705709
NCBI chr 8:75,811,985...75,980,049
Ensembl chr 8:75,812,412...75,975,918
G
Myocd
myocardin
increases expression
ISO
geldanamycin results in increased expression of MYOCD mRNA
CTD
PMID:26705709
NCBI chr10:49,833,219...49,928,806
Ensembl chr10:49,836,641...49,927,627
G
Mzt1
mitotic spindle organizing protein 1
increases expression
ISO
geldanamycin results in increased expression of MZT1 mRNA
CTD
PMID:26705709
NCBI chr15:75,787,281...75,797,589
Ensembl chr15:75,786,994...75,797,589
G
Nasp
nuclear autoantigenic sperm protein
increases expression
ISO
geldanamycin results in increased expression of NASP mRNA
CTD
PMID:26705709
NCBI chr 5:130,057,363...130,083,003
Ensembl chr 5:130,057,363...130,082,928
G
Nbas
NBAS subunit of NRZ tethering complex
increases expression
ISO
geldanamycin results in increased expression of NBAS mRNA
CTD
PMID:26705709
NCBI chr 6:36,048,357...36,353,206
Ensembl chr 6:36,048,191...36,352,984
G
Ncoa2
nuclear receptor coactivator 2
increases expression
ISO
geldanamycin results in increased expression of NCOA2 mRNA
CTD
PMID:26705709
NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:5,835,706...6,067,451
G
Nedd9
neural precursor cell expressed, developmentally down-regulated 9
increases expression
ISO
geldanamycin results in increased expression of NEDD9 mRNA
CTD
PMID:26705709
NCBI chr17:23,289,793...23,468,026
Ensembl chr17:23,282,326...23,468,019
G
Nes
nestin
increases expression
ISO
geldanamycin results in increased expression of NES mRNA
CTD
PMID:26705709
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
G
Nf1
neurofibromin 1
increases expression
ISO
geldanamycin results in increased expression of NF1 mRNA
CTD
PMID:26705709
NCBI chr10:64,306,027...64,539,112
Ensembl chr10:64,306,301...64,536,658
G
Nf2
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
increases expression
ISO
geldanamycin results in increased expression of NF2 mRNA
CTD
PMID:26705709
NCBI chr14:79,627,399...79,710,709
Ensembl chr14:79,627,399...79,710,667
G
Nfat5
nuclear factor of activated T-cells 5
increases expression
ISO
geldanamycin results in increased expression of NFAT5 mRNA
CTD
PMID:26705709
NCBI chr19:35,199,737...35,286,675
Ensembl chr19:35,199,016...35,286,675
G
Nipbl
NIPBL, cohesin loading factor
increases expression
ISO
geldanamycin results in increased expression of NIPBL mRNA
CTD
PMID:26705709
NCBI chr 2:57,399,443...57,586,770
Ensembl chr 2:57,399,445...57,565,899
G
Nktr
natural killer cell triggering receptor
increases expression
ISO
geldanamycin results in increased expression of NKTR mRNA
CTD
PMID:26705709
NCBI chr 8:121,380,010...121,420,495
Ensembl chr 8:121,382,436...121,418,314
G
Nos2
nitric oxide synthase 2
multiple interactions decreases expression
EXP ISO
geldanamycin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; Quercetin inhibits the reaction [geldanamycin results in decreased expression of NOS2 mRNA] geldanamycin inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]
CTD
PMID:11835313 PMID:15583003 PMID:37586545
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Npr3
natriuretic peptide receptor 3
increases expression
ISO
geldanamycin results in increased expression of NPR3 mRNA
CTD
PMID:26705709
NCBI chr 2:60,865,483...60,933,432
Ensembl chr 2:60,870,594...60,932,955
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases reduction
ISO
NQO1 protein results in increased reduction of geldanamycin
CTD
PMID:16825487
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr2c2
nuclear receptor subfamily 2, group C, member 2
increases expression
ISO
geldanamycin results in increased expression of NR2C2 mRNA
CTD
PMID:26705709
NCBI chr 4:124,610,216...124,666,813
Ensembl chr 4:124,608,960...124,661,902
G
Nrk
Nik related kinase
increases expression
ISO
geldanamycin results in increased expression of NRK mRNA
CTD
PMID:26705709
NCBI chr X:102,365,765...102,462,957
Ensembl chr X:102,365,765...102,459,657
G
Osbpl8
oxysterol binding protein-like 8
increases expression
ISO
geldanamycin results in increased expression of OSBPL8 mRNA
CTD
PMID:26705709
NCBI chr 7:46,596,944...46,749,888
Ensembl chr 7:46,596,983...46,749,888
G
Otud4
OTU deubiquitinase 4
increases expression
ISO
geldanamycin results in increased expression of OTUD4 mRNA
CTD
PMID:26705709
NCBI chr19:28,236,713...28,279,815
Ensembl chr19:28,236,713...28,279,815
G
Oxtr
oxytocin receptor
increases expression
ISO
geldanamycin results in increased expression of OXTR mRNA
CTD
PMID:26705709
NCBI chr 4:145,598,549...145,614,674
Ensembl chr 4:145,599,561...145,614,674
G
P2rx1
purinergic receptor P2X 1
multiple interactions
EXP
geldanamycin promotes the reaction [Adenosine Triphosphate results in increased activity of P2RX1]
CTD
PMID:11930156
NCBI chr10:57,618,586...57,633,648
Ensembl chr10:57,618,586...57,633,623
G
Pappa
pappalysin
increases expression
ISO
geldanamycin results in increased expression of PAPPA mRNA
CTD
PMID:26705709
NCBI chr 5:78,497,660...78,735,873
Ensembl chr 5:78,498,300...78,730,666
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions increases degradation
ISO
geldanamycin inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein]; Tretinoin inhibits the reaction [geldanamycin results in increased degradation of PARP1 protein]
CTD
PMID:16311509 PMID:17293044
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pcbp2
poly(rC) binding protein 2
increases expression
ISO
geldanamycin results in increased expression of PCBP2 mRNA
CTD
PMID:26705709
NCBI chr 7:133,605,375...133,631,312
Ensembl chr 7:133,605,573...133,629,863
G
Pcm1
pericentriolar material 1
increases expression
ISO
geldanamycin results in increased expression of PCM1 mRNA
CTD
PMID:26705709
NCBI chr16:51,008,315...51,105,261
Ensembl chr16:51,008,315...51,105,091
G
Pde4dip
phosphodiesterase 4D interacting protein
increases expression
ISO
geldanamycin results in increased expression of PDE4DIP mRNA
CTD
PMID:26705709
NCBI chr 2:185,293,236...185,490,100
Ensembl chr 2:185,293,214...185,468,379
G
Pdgfa
platelet derived growth factor subunit A
increases expression
ISO
geldanamycin results in increased expression of PDGFA mRNA
CTD
PMID:26705709
NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
G
Peg10
paternally expressed 10
increases expression
ISO
geldanamycin results in increased expression of PEG10 mRNA
CTD
PMID:26705709
NCBI chr 4:32,842,441...32,855,639
Ensembl chr 4:32,848,493...32,852,621
G
Pgr
progesterone receptor
decreases expression
ISO
geldanamycin results in decreased expression of PGR protein
CTD
PMID:11448926
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
G
Phactr2
phosphatase and actin regulator 2
increases expression
ISO
geldanamycin results in increased expression of PHACTR2 mRNA
CTD
PMID:26705709
NCBI chr 1:7,591,254...7,860,431
Ensembl chr 1:7,597,927...7,860,289
G
Phldb2
pleckstrin homology-like domain, family B, member 2
increases expression
ISO
geldanamycin results in increased expression of PHLDB2 mRNA
CTD
PMID:26705709
NCBI chr11:54,859,173...55,078,212
Ensembl chr11:54,859,135...55,078,467
G
Phtf2
putative homeodomain transcription factor 2
increases expression
ISO
geldanamycin results in increased expression of PHTF2 mRNA
CTD
PMID:26705709
NCBI chr 4:14,215,190...14,330,549
Ensembl chr 4:14,215,263...14,330,513
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
increases expression
ISO
geldanamycin results in increased expression of PIK3CA mRNA
CTD
PMID:26705709
NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
increases expression
ISO
geldanamycin results in increased expression of PIK3R1 mRNA
CTD
PMID:26705709
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
G
Plau
plasminogen activator, urokinase
multiple interactions
ISO
[geldanamycin co-treated with PTHLH protein modified form] results in decreased expression of PLAU mRNA
CTD
PMID:12724357
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Plppr4
phospholipid phosphatase related 4
increases expression
ISO
geldanamycin results in increased expression of PLPPR4 mRNA
CTD
PMID:26705709
NCBI chr 2:205,371,317...205,412,302
Ensembl chr 2:205,371,322...205,412,302
G
Plxna2
plexin A2
increases expression
ISO
geldanamycin results in increased expression of PLXNA2 mRNA
CTD
PMID:26705709
NCBI chr13:106,163,103...106,358,979
Ensembl chr13:106,163,103...106,358,979
G
Polr2b
RNA polymerase II subunit B
decreases expression
ISO
geldanamycin results in decreased expression of POLR2B mRNA
CTD
PMID:30166341
NCBI chr14:30,797,228...30,834,916
Ensembl chr14:30,797,228...30,834,916
G
Ppm1k
protein phosphatase, Mg2+/Mn2+ dependent, 1K
increases expression
ISO
geldanamycin results in increased expression of PPM1K mRNA
CTD
PMID:26705709
NCBI chr 4:87,612,198...87,638,993
Ensembl chr 4:87,612,204...87,636,152
G
Prkaa1
protein kinase AMP-activated catalytic subunit alpha 1
multiple interactions
ISO
Bortezomib inhibits the reaction [geldanamycin results in decreased expression of and results in decreased phosphorylation of PRKAA1 protein]; geldanamycin results in decreased expression of and results in decreased phosphorylation of PRKAA1 protein
CTD
PMID:37481222
NCBI chr 2:54,240,298...54,275,978
Ensembl chr 2:54,240,137...54,275,978
G
Prkaa2
protein kinase AMP-activated catalytic subunit alpha 2
multiple interactions
ISO
Bortezomib inhibits the reaction [geldanamycin results in decreased expression of and results in decreased phosphorylation of PRKAA2 protein]; geldanamycin results in decreased expression of and results in decreased phosphorylation of PRKAA2 protein
CTD
PMID:37481222
NCBI chr 5:119,807,992...119,879,987
Ensembl chr 5:119,813,226...119,879,543
G
Prkg1
protein kinase cGMP-dependent 1
increases expression
ISO
geldanamycin results in increased expression of PRKG1 mRNA
CTD
PMID:26705709
NCBI chr 1:228,409,605...229,638,794
Ensembl chr 1:228,408,947...229,639,080
G
Prmt2
protein arginine methyltransferase 2
increases expression
ISO
geldanamycin results in increased expression of PRMT2 mRNA
CTD
PMID:26705709
NCBI chr20:12,394,748...12,420,643
Ensembl chr20:12,394,798...12,420,643
G
Prpf6
pre-mRNA processing factor 6
increases expression
ISO
geldanamycin results in increased expression of PRPF6 mRNA
CTD
PMID:26705709
NCBI chr 3:168,706,952...168,771,191
Ensembl chr 3:168,704,299...168,774,991
G
Prr14l
proline rich 14-like
increases expression
ISO
geldanamycin results in increased expression of PRR14L mRNA
CTD
PMID:26705709
NCBI chr14:77,869,848...77,937,141
Ensembl chr14:77,869,799...77,936,521
G
Prrc2c
proline-rich coiled-coil 2C
increases expression
ISO
geldanamycin results in increased expression of PRRC2C mRNA
CTD
PMID:26705709
NCBI chr13:75,003,995...75,073,701
Ensembl chr13:75,004,010...75,073,643
G
Psme4
proteasome activator subunit 4
increases expression
ISO
geldanamycin results in increased expression of PSME4 mRNA
CTD
PMID:26705709
NCBI chr14:104,505,716...104,609,410
Ensembl chr14:104,505,716...104,609,408
G
Ptar1
protein prenyltransferase alpha subunit repeat containing 1
increases expression
ISO
geldanamycin results in increased expression of PTAR1 mRNA
CTD
PMID:26705709
NCBI chr 1:221,283,306...221,326,861
Ensembl chr 1:221,283,415...221,327,073
G
Ptbp3
polypyrimidine tract binding protein 3
increases expression
ISO
geldanamycin results in increased expression of PTBP3 mRNA
CTD
PMID:26705709
NCBI chr 5:74,313,367...74,399,439
Ensembl chr 5:74,315,101...74,399,791
G
Ptgs1
prostaglandin-endoperoxide synthase 1
decreases expression
ISO
geldanamycin results in decreased expression of PTGS1 mRNA
CTD
PMID:26705709
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [[CEBPB protein binds to CEBPB protein] which binds to PTGS2 promoter]]; geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]
CTD
PMID:11133817
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Pthlh
parathyroid hormone-like hormone
multiple interactions
ISO
[geldanamycin co-treated with PTHLH protein modified form] results in decreased expression of PLAU mRNA; [geldanamycin co-treated with PTHLH protein modified form] results in increased expression of MMP1 mRNA
CTD
PMID:12724357
NCBI chr 4:180,188,792...180,199,847
Ensembl chr 4:180,188,792...180,199,847
G
Ptk2
protein tyrosine kinase 2
increases degradation decreases phosphorylation
ISO
geldanamycin results in increased degradation of PTK2 protein geldanamycin results in decreased phosphorylation of PTK2 protein
CTD
PMID:9973544 PMID:12811834
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
G
Ptpn11
protein tyrosine phosphatase, non-receptor type 11
increases expression
ISO
geldanamycin results in increased expression of PTPN11 mRNA
CTD
PMID:26705709
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
G
Ptpn12
protein tyrosine phosphatase, non-receptor type 12
increases expression
ISO
geldanamycin results in increased expression of PTPN12 mRNA
CTD
PMID:26705709
NCBI chr 4:14,020,997...14,092,931
Ensembl chr 4:14,021,052...14,092,927
G
Ptpra
protein tyrosine phosphatase, receptor type, A
increases expression
ISO
geldanamycin results in increased expression of PTPRA mRNA
CTD
PMID:26705709
NCBI chr 3:117,650,146...117,759,744
Ensembl chr 3:117,650,183...117,759,728
G
Ptprd
protein tyrosine phosphatase, receptor type, D
increases expression
ISO
geldanamycin results in increased expression of PTPRD mRNA
CTD
PMID:26705709
NCBI chr 5:90,046,993...90,698,977 NCBI chr 5:91,122,354...91,641,754
Ensembl chr 5:90,048,966...92,369,396
G
Pygo1
pygopus family PHD finger 1
increases expression
ISO
geldanamycin results in increased expression of PYGO1 mRNA
CTD
PMID:26705709
NCBI chr 8:73,666,210...73,684,873
Ensembl chr 8:73,665,593...73,684,869
G
Rab3b
RAB3B, member RAS oncogene family
increases expression
ISO
geldanamycin results in increased expression of RAB3B mRNA
CTD
PMID:26705709
NCBI chr 5:123,629,562...123,697,410
Ensembl chr 5:123,644,423...123,697,401
G
Rabep1
rabaptin, RAB GTPase binding effector protein 1
increases expression
ISO
geldanamycin results in increased expression of RABEP1 mRNA
CTD
PMID:26705709
NCBI chr10:55,566,156...55,667,595
Ensembl chr10:55,566,185...55,665,973
G
Raf1
Raf-1 proto-oncogene, serine/threonine kinase
increases expression decreases expression multiple interactions
ISO
geldanamycin results in increased expression of RAF1 protein geldanamycin results in decreased expression of RAF1 protein geldanamycin results in decreased expression of and results in decreased phosphorylation of RAF1 protein
CTD
PMID:8816498 PMID:19167484 PMID:24450340
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
G
Rapgef2
Rap guanine nucleotide exchange factor 2
increases expression
ISO
geldanamycin results in increased expression of RAPGEF2 mRNA
CTD
PMID:26705709
NCBI chr 2:164,207,513...164,322,157
Ensembl chr 2:164,207,513...164,244,247
G
Rassf8
Ras association domain family member 8
increases expression
ISO
geldanamycin results in increased expression of RASSF8 mRNA
CTD
PMID:26705709
NCBI chr 4:178,716,110...178,798,042
Ensembl chr 4:178,719,992...178,796,690
G
Rbak
RB-associated KRAB zinc finger
increases expression
ISO
geldanamycin results in increased expression of RBAK mRNA
CTD
PMID:26705709
NCBI chr12:11,375,314...11,388,937
Ensembl chr12:11,375,318...11,388,934
G
Rbm26
RNA binding motif protein 26
increases expression
ISO
geldanamycin results in increased expression of RBM26 mRNA
CTD
PMID:26705709
NCBI chr15:81,884,783...81,964,245
Ensembl chr15:81,887,219...81,964,118
G
Rbms3
RNA binding motif, single stranded interacting protein 3
increases expression
ISO
geldanamycin results in increased expression of RBMS3 mRNA
CTD
PMID:26705709
NCBI chr 8:116,305,227...117,625,730
Ensembl chr 8:116,309,882...117,625,423
G
Rcan1
regulator of calcineurin 1
increases expression
ISO
geldanamycin results in increased expression of RCAN1 mRNA
CTD
PMID:26705709
NCBI chr11:31,622,208...31,702,150
Ensembl chr11:31,622,210...31,702,045
G
Rdh10
retinol dehydrogenase 10
increases expression
ISO
geldanamycin results in increased expression of RDH10 mRNA
CTD
PMID:26705709
NCBI chr 5:3,186,671...3,215,572
Ensembl chr 5:3,188,445...3,215,572
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
geldanamycin inhibits the reaction [TNF protein affects the localization of RELA protein]; geldanamycin inhibits the reaction [TNF protein results in increased expression of RELA mRNA]
CTD
PMID:37586545
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Resf1
retroelement silencing factor 1
increases expression
ISO
geldanamycin results in increased expression of KIAA1551 mRNA
CTD
PMID:26705709
NCBI chr 4:182,325,913...182,362,054
Ensembl chr 4:182,335,454...182,362,054
G
Rfx7
regulatory factor X, 7
increases expression
ISO
geldanamycin results in increased expression of RFX7 mRNA
CTD
PMID:26705709
NCBI chr 8:73,254,051...73,339,209
Ensembl chr 8:73,254,051...73,339,209
G
Rngtt
RNA guanylyltransferase and 5'-phosphatase
increases expression decreases expression
ISO
geldanamycin results in increased expression of RNGTT mRNA geldanamycin results in decreased expression of RNGTT protein
CTD
PMID:26705709 PMID:30166341
NCBI chr 5:47,706,929...47,913,297
Ensembl chr 5:47,706,799...47,913,295
G
Ro60
Ro60, Y RNA binding protein
increases expression
ISO
geldanamycin results in increased expression of TROVE2 mRNA
CTD
PMID:26705709
NCBI chr13:55,499,514...55,520,504
Ensembl chr13:55,499,534...55,520,504
G
Rock2
Rho-associated coiled-coil containing protein kinase 2
increases expression
ISO
geldanamycin results in increased expression of ROCK2 mRNA
CTD
PMID:26705709
NCBI chr 6:39,679,116...39,774,033
Ensembl chr 6:39,679,082...39,774,031
G
Rplp0
ribosomal protein lateral stalk subunit P0
decreases expression
ISO
geldanamycin results in decreased expression of RPLP0 mRNA
CTD
PMID:30166341
NCBI chr12:41,054,363...41,057,632
Ensembl chr12:41,054,179...41,057,632
G
Rttn
rotatin
increases expression
ISO
geldanamycin results in increased expression of RTTN mRNA
CTD
PMID:26705709
NCBI chr18:82,220,999...82,398,334
Ensembl chr18:82,221,050...82,398,333
G
Rufy2
RUN and FYVE domain containing 2
increases expression
ISO
geldanamycin results in increased expression of RUFY2 mRNA
CTD
PMID:26705709
NCBI chr20:25,626,958...25,658,157
Ensembl chr20:25,621,999...25,658,186
G
S100a4
S100 calcium-binding protein A4
decreases expression
ISO
geldanamycin results in decreased expression of S100A4 mRNA
CTD
PMID:26705709
NCBI chr 2:176,090,951...176,093,258
Ensembl chr 2:176,091,804...176,093,254
G
Samd5
sterile alpha motif domain containing 5
increases expression
ISO
geldanamycin results in increased expression of SAMD5 mRNA
CTD
PMID:26705709
NCBI chr 1:4,041,547...4,090,909
Ensembl chr 1:3,677,784...4,091,120
G
Sar1b
secretion associated, Ras related GTPase 1B
increases expression
ISO
geldanamycin results in increased expression of SAR1B mRNA
CTD
PMID:26705709
NCBI chr10:36,024,415...36,054,069
Ensembl chr10:36,024,382...36,054,066
G
Scrn3
secernin 3
increases expression
ISO
geldanamycin results in increased expression of SCRN3 mRNA
CTD
PMID:26705709
NCBI chr 3:58,188,820...58,213,623
Ensembl chr 3:58,188,889...58,213,623
G
Scyl2
SCY1 like pseudokinase 2
increases expression
ISO
geldanamycin results in increased expression of SCYL2 mRNA
CTD
PMID:26705709
NCBI chr 7:24,064,404...24,117,338
Ensembl chr 7:24,064,404...24,117,305
G
Sema3d
semaphorin 3D
increases expression
ISO
geldanamycin results in increased expression of SEMA3D mRNA
CTD
PMID:26705709
NCBI chr 4:22,316,769...22,505,930
Ensembl chr 4:22,316,779...22,505,930
G
Senp1
SUMO specific peptidase 1
increases expression
ISO
geldanamycin results in increased expression of SENP1 mRNA
CTD
PMID:26705709
NCBI chr 7:129,163,173...129,226,766
Ensembl chr 7:129,165,774...129,221,598
G
Serpine1
serpin family E member 1
increases expression
ISO
geldanamycin results in increased expression of SERPINE1 mRNA
CTD
PMID:26705709
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Sesn3
sestrin 3
increases expression
ISO
geldanamycin results in increased expression of SESN3 mRNA
CTD
PMID:26705709
NCBI chr 8:11,133,822...11,189,436
Ensembl chr 8:11,133,678...11,185,842
G
Setd2
SET domain containing 2, histone lysine methyltransferase
increases expression
ISO
geldanamycin results in increased expression of SETD2 mRNA
CTD
PMID:26705709
NCBI chr 8:110,511,808...110,597,475
Ensembl chr 8:110,511,772...110,597,489
G
Setx
senataxin
increases expression
ISO
geldanamycin results in increased expression of SETX mRNA
CTD
PMID:26705709
NCBI chr 3:12,428,091...12,480,801
Ensembl chr 3:12,427,635...12,480,803
G
Sfpq
splicing factor proline and glutamine rich
increases expression
ISO
geldanamycin results in increased expression of SFPQ mRNA
CTD
PMID:26705709
NCBI chr 5:139,338,034...139,353,476
Ensembl chr 5:139,338,075...139,353,472
G
Sgms2
sphingomyelin synthase 2
increases expression
ISO
geldanamycin results in increased expression of SGMS2 mRNA
CTD
PMID:26705709
NCBI chr 2:219,889,809...219,967,704
Ensembl chr 2:219,893,572...219,967,546
G
Sike1
suppressor of IKBKE 1
increases expression
ISO
geldanamycin results in increased expression of SIKE1 mRNA
CTD
PMID:26705709
NCBI chr 2:190,518,002...190,525,833
Ensembl chr 2:190,518,002...190,525,832
G
Skic3
SKI3 subunit of superkiller complex
increases expression
ISO
geldanamycin results in increased expression of SKIC3 mRNA
CTD
PMID:26705709
NCBI chr 2:5,631,544...5,783,643
Ensembl chr 2:5,631,635...5,751,626
G
Slain2
SLAIN motif family, member 2
increases expression
ISO
geldanamycin results in increased expression of SLAIN2 mRNA
CTD
PMID:26705709
NCBI chr14:35,236,034...35,314,186
Ensembl chr14:35,236,041...35,304,678
G
Slc16a1
solute carrier family 16 member 1
increases expression
ISO
geldanamycin results in increased expression of SLC16A1 mRNA
CTD
PMID:26705709
NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:192,124,289...192,144,611
G
Slc16a7
solute carrier family 16 member 7
increases expression
ISO
geldanamycin results in increased expression of SLC16A7 mRNA
CTD
PMID:26705709
NCBI chr 7:61,043,667...61,211,547
Ensembl chr 7:61,051,167...61,154,994
G
Slc2a13
solute carrier family 2 member 13
increases expression
ISO
geldanamycin results in increased expression of SLC2A13 mRNA
CTD
PMID:26705709
NCBI chr 7:122,399,329...122,726,605
Ensembl chr 7:122,399,330...122,726,605
G
Slc38a1
solute carrier family 38, member 1
increases expression
ISO
geldanamycin results in increased expression of SLC38A1 mRNA
CTD
PMID:26705709
NCBI chr 7:127,733,230...127,802,541
Ensembl chr 7:127,738,226...127,802,218
G
Slc39a6
solute carrier family 39 member 6
increases expression
ISO
geldanamycin results in increased expression of SLC39A6 mRNA
CTD
PMID:26705709
NCBI chr18:15,864,874...15,885,417
Ensembl chr18:15,864,875...15,885,417
G
Slc8a1
solute carrier family 8 member A1
increases expression
ISO
geldanamycin results in increased expression of SLC8A1 mRNA
CTD
PMID:26705709
NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
G
Slfn5
schlafen family member 5
increases expression
ISO
geldanamycin results in increased expression of SLFN5 mRNA
CTD
PMID:26705709
NCBI chr10:67,881,068...67,895,013
Ensembl chr10:67,880,009...67,893,109
G
Smarca2
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
increases expression
ISO
geldanamycin results in increased expression of SMARCA2 mRNA
CTD
PMID:26705709
NCBI chr 1:224,191,125...224,358,640
Ensembl chr 1:224,191,125...224,358,684
G
Smc1a
structural maintenance of chromosomes 1A
increases expression
ISO
geldanamycin results in increased expression of SMC1A mRNA
CTD
PMID:26705709
NCBI chr X:21,103,323...21,148,053
Ensembl chr X:21,103,282...21,148,056
G
Smchd1
structural maintenance of chromosomes flexible hinge domain containing 1
increases expression
ISO
geldanamycin results in increased expression of SMCHD1 mRNA
CTD
PMID:26705709
NCBI chr 9:111,243,445...111,387,272
Ensembl chr 9:111,247,702...111,349,665
G
Sos2
SOS Ras/Rho guanine nucleotide exchange factor 2
increases expression
ISO
geldanamycin results in increased expression of SOS2 mRNA
CTD
PMID:26705709
NCBI chr 6:88,042,966...88,156,140
Ensembl chr 6:88,042,966...88,156,692
G
Sp4
Sp4 transcription factor
increases expression
ISO
geldanamycin results in increased expression of SP4 mRNA
CTD
PMID:26705709
NCBI chr 6:139,187,458...139,252,741
Ensembl chr 6:139,192,147...139,252,126
G
Sptbn1
spectrin, beta, non-erythrocytic 1
increases expression
ISO
geldanamycin results in increased expression of SPTBN1 mRNA
CTD
PMID:26705709
NCBI chr14:103,841,713...104,016,900
Ensembl chr14:103,842,684...104,008,507
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
multiple interactions
ISO EXP
geldanamycin inhibits the reaction [HSP90AA1 protein binds to SRC protein binds to CDC37 protein]; geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of SRC protein] geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased localization of SRC protein]
CTD
PMID:10401681 PMID:17223712
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
G
Srpra
SRP receptor subunit alpha
increases expression
ISO
geldanamycin results in increased expression of SRPRA mRNA
CTD
PMID:26705709
NCBI chr 8:33,560,365...33,566,458
Ensembl chr 8:33,560,348...33,566,470
G
Srrm2
serine/arginine repetitive matrix 2
increases expression
ISO
geldanamycin results in increased expression of SRRM2 mRNA
CTD
PMID:26705709
NCBI chr10:12,815,471...12,848,750
Ensembl chr10:12,815,471...12,848,751
G
Srrt
serrate, RNA effector molecule
increases expression
ISO
geldanamycin results in increased expression of SRRT mRNA
CTD
PMID:26705709
NCBI chr12:19,392,578...19,406,098
Ensembl chr12:19,392,625...19,406,095
G
Stk11
serine/threonine kinase 11
multiple interactions
ISO
Bortezomib inhibits the reaction [geldanamycin results in decreased expression of and results in decreased phosphorylation of STK11 protein]; geldanamycin results in decreased expression of and results in decreased phosphorylation of STK11 protein
CTD
PMID:37481222
NCBI chr 7:9,574,553...9,591,315
Ensembl chr 7:9,575,269...9,591,315
G
Strn4
striatin 4
decreases expression
ISO
geldanamycin results in decreased expression of STRN4 mRNA
CTD
PMID:30166341
NCBI chr 1:77,482,267...77,511,862
Ensembl chr 1:77,482,094...77,511,858
G
Stub1
STIP1 homology and U-box containing protein 1
multiple interactions
ISO
geldanamycin inhibits the reaction [solanesol promotes the reaction [HSF1 protein binds to STUB1 protein]]; geldanamycin promotes the reaction [ESR1 protein binds to STUB1 protein]; STUB1 protein promotes the reaction [geldanamycin results in increased degradation of ESR1 protein]
CTD
PMID:16037132 PMID:25645596
NCBI chr10:14,850,765...14,853,046
Ensembl chr10:14,850,765...14,853,046
G
Supt16h
SPT16 homolog, facilitates chromatin remodeling subunit
increases expression
ISO
geldanamycin results in increased expression of SUPT16H mRNA
CTD
PMID:26705709
NCBI chr15:24,867,697...24,904,818
Ensembl chr15:24,866,489...24,904,846
G
Tead1
TEA domain transcription factor 1
increases expression
ISO
geldanamycin results in increased expression of TEAD1 mRNA
CTD
PMID:26705709
NCBI chr 1:166,791,900...167,010,591
Ensembl chr 1:166,792,628...167,003,369
G
Tet2
tet methylcytosine dioxygenase 2
increases expression
ISO
geldanamycin results in increased expression of TET2 mRNA
CTD
PMID:26705709
NCBI chr 2:221,988,645...222,072,813
Ensembl chr 2:221,988,645...222,072,534
G
Tfpi
tissue factor pathway inhibitor
increases expression
ISO
geldanamycin results in increased expression of TFPI mRNA
CTD
PMID:26705709
NCBI chr 3:69,533,156...69,582,547
Ensembl chr 3:69,533,156...69,576,880
G
Tgfb2
transforming growth factor, beta 2
increases expression
ISO
geldanamycin results in increased expression of TGFB2 mRNA
CTD
PMID:26705709
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
G
Thbs1
thrombospondin 1
increases expression
ISO
geldanamycin results in increased expression of THBS1 mRNA
CTD
PMID:26705709
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Tle4
TLE family member 4, transcriptional corepressor
increases expression
ISO
geldanamycin results in increased expression of TLE4 mRNA
CTD
PMID:26705709
NCBI chr 1:211,661,738...211,798,458
Ensembl chr 1:211,661,746...211,797,862
G
Tlk1
tousled-like kinase 1
increases expression
ISO
geldanamycin results in increased expression of TLK1 mRNA
CTD
PMID:26705709
NCBI chr 3:55,520,559...55,627,580
Ensembl chr 3:55,503,358...55,691,968
G
Tll1
tolloid-like 1
increases expression
ISO
geldanamycin results in increased expression of TLL1 mRNA
CTD
PMID:26705709
NCBI chr16:25,509,146...25,710,330
Ensembl chr16:25,509,146...25,709,543
G
Tlr4
toll-like receptor 4
increases expression
ISO
geldanamycin results in increased expression of TLR4 mRNA
CTD
PMID:26705709
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tmem33
transmembrane protein 33
increases expression
ISO
geldanamycin results in increased expression of TMEM33 mRNA
CTD
PMID:26705709
NCBI chr14:40,888,485...40,910,715
Ensembl chr14:40,885,712...40,910,715
G
Tmod3
tropomodulin 3
increases expression
ISO
geldanamycin results in increased expression of TMOD3 mRNA
CTD
PMID:26705709
NCBI chr 8:76,248,978...76,310,855
Ensembl chr 8:76,248,979...76,310,977
G
Tmtc3
transmembrane O-mannosyltransferase targeting cadherins 3
increases expression
ISO
geldanamycin results in increased expression of TMTC3 mRNA
CTD
PMID:26705709
NCBI chr 7:35,264,886...35,310,010
Ensembl chr 7:35,264,892...35,310,385
G
Tnf
tumor necrosis factor
multiple interactions
ISO
geldanamycin inhibits the reaction [TNF protein affects the localization of RELA protein]; geldanamycin inhibits the reaction [TNF protein results in increased expression of ABCB1 mRNA]; geldanamycin inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA]; geldanamycin inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; geldanamycin inhibits the reaction [TNF protein results in increased expression of CXCL8 protein]; geldanamycin inhibits the reaction [TNF protein results in increased expression of EGFR mRNA]; geldanamycin inhibits the reaction [TNF protein results in increased expression of HIF1A mRNA]; geldanamycin inhibits the reaction [TNF protein results in increased expression of IL1B mRNA]; geldanamycin inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]; geldanamycin inhibits the reaction [TNF protein results in increased expression of RELA mRNA] geldanamycin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF mRNA]
CTD
PMID:11472980 PMID:12571865 PMID:37586545
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfsf15
TNF superfamily member 15
decreases expression
ISO
geldanamycin results in decreased expression of TNFSF15 mRNA
CTD
PMID:26705709
NCBI chr 5:77,134,885...77,156,171
Ensembl chr 5:77,139,878...77,156,228
G
Tnks2
tankyrase 2
increases expression
ISO
geldanamycin results in increased expression of TNKS2 mRNA
CTD
PMID:26705709
NCBI chr 1:234,567,888...234,621,079
Ensembl chr 1:234,567,858...234,621,079
G
Tob2
transducer of ERBB2, 2
increases expression
ISO
geldanamycin results in increased expression of TOB2 mRNA
CTD
PMID:26705709
NCBI chr 7:113,362,703...113,371,423
Ensembl chr 7:113,361,148...113,372,688
G
Tp53
tumor protein p53
affects localization affects expression multiple interactions
ISO
geldanamycin affects the localization of TP53 protein geldanamycin affects the expression of TP53 protein Tretinoin inhibits the reaction [geldanamycin affects the localization of TP53 protein]
CTD
PMID:17293044 PMID:24211270
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp53bp1
tumor protein p53 binding protein 1
increases expression
ISO
geldanamycin results in increased expression of TP53BP1 mRNA
CTD
PMID:26705709
NCBI chr 3:108,166,574...108,270,229
Ensembl chr 3:108,169,980...108,269,822
G
Tpm4
tropomyosin 4
increases expression
ISO
geldanamycin results in increased expression of TPM4 mRNA
CTD
PMID:26705709
NCBI chr16:17,684,415...17,698,456
Ensembl chr16:17,683,195...17,705,984
G
Tpp2
tripeptidyl peptidase 2
increases expression
ISO
geldanamycin results in increased expression of TPP2 mRNA
CTD
PMID:26705709
NCBI chr 9:46,046,712...46,128,157
Ensembl chr 9:46,046,632...46,128,157
G
Tpr
translocated promoter region, nuclear basket protein
increases expression
ISO
geldanamycin results in increased expression of TPR mRNA
CTD
PMID:26705709
NCBI chr13:62,424,312...62,487,502
Ensembl chr13:62,424,312...62,487,496
G
Trim59
tripartite motif-containing 59
increases expression
ISO
geldanamycin results in increased expression of TRIM59 mRNA
CTD
PMID:26705709
NCBI chr 2:153,269,210...153,281,185
Ensembl chr 2:153,268,584...153,281,031
G
Trpc6
transient receptor potential cation channel, subfamily C, member 6
increases expression
ISO
geldanamycin results in increased expression of TRPC6 mRNA
CTD
PMID:26705709
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
G
Trpv1
transient receptor potential cation channel, subfamily V, member 1
multiple interactions
EXP
geldanamycin affects the reaction [Capsaicin results in increased activity of TRPV1]
CTD
PMID:11930156
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
G
Ttc3
tetratricopeptide repeat domain 3
increases expression
ISO
geldanamycin results in increased expression of TTC3 mRNA
CTD
PMID:26705709
NCBI chr11:33,689,119...33,788,976
Ensembl chr11:33,688,952...33,788,975
G
Tuba1a
tubulin, alpha 1A
decreases expression
ISO
geldanamycin results in decreased expression of TUBA1A mRNA
CTD
PMID:27015953
NCBI chr 7:130,113,214...130,116,880
Ensembl chr 7:130,081,032...130,196,186
G
Ube2h
ubiquitin-conjugating enzyme E2H
increases expression
ISO
geldanamycin results in increased expression of UBE2H mRNA
CTD
PMID:26705709
NCBI chr 4:58,834,674...58,930,156
Ensembl chr 4:58,834,674...58,930,156
G
Ubn2
ubinuclein 2
increases expression
ISO
geldanamycin results in increased expression of UBN2 mRNA
CTD
PMID:26705709
NCBI chr 4:67,165,278...67,251,562
Ensembl chr 4:67,166,346...67,230,491
G
Ugcg
UDP-glucose ceramide glucosyltransferase
increases expression
ISO
geldanamycin results in increased expression of UGCG mRNA
CTD
PMID:26705709
NCBI chr 5:74,032,978...74,065,701
Ensembl chr 5:74,032,978...74,065,393
G
Uggt1
UDP-glucose glycoprotein glucosyltransferase 1
increases expression
ISO
geldanamycin results in increased expression of UGGT1 mRNA
CTD
PMID:26705709
NCBI chr 9:38,355,229...38,468,473
Ensembl chr 9:38,359,089...38,468,467
G
Uhmk1
U2AF homology motif kinase 1
increases expression
ISO
geldanamycin results in increased expression of UHMK1 mRNA
CTD
PMID:26705709
NCBI chr13:82,396,646...82,416,292
Ensembl chr13:82,401,187...82,416,292
G
Usp10
ubiquitin specific peptidase 10
increases expression
ISO
geldanamycin results in increased expression of USP10 mRNA
CTD
PMID:26705709
NCBI chr19:47,972,858...48,014,900
Ensembl chr19:47,972,611...48,014,897
G
Usp12
ubiquitin specific peptidase 12
increases expression
ISO
geldanamycin results in increased expression of USP12 mRNA
CTD
PMID:26705709
NCBI chr12:8,309,845...8,363,686
Ensembl chr12:8,309,750...8,363,656
G
Usp25
ubiquitin specific peptidase 25
increases expression
ISO
geldanamycin results in increased expression of USP25 mRNA
CTD
PMID:26705709
NCBI chr11:15,603,654...15,711,356
Ensembl chr11:15,603,881...15,711,348
G
Usp36
ubiquitin specific peptidase 36
increases expression
ISO
geldanamycin results in increased expression of USP36 mRNA
CTD
PMID:26705709
NCBI chr10:103,497,349...103,528,877
Ensembl chr10:103,497,349...103,528,877
G
Vapb
VAMP associated protein B and C
increases expression
ISO
geldanamycin results in increased expression of VAPB mRNA
CTD
PMID:26705709
NCBI chr 3:162,535,974...162,578,747
Ensembl chr 3:162,535,905...162,573,763
G
Vdac3
voltage-dependent anion channel 3
decreases expression
ISO
geldanamycin results in decreased expression of VDAC3 mRNA
CTD
PMID:30166341
NCBI chr16:69,434,982...69,451,473
Ensembl chr16:69,435,005...69,451,471
G
Vldlr
very low density lipoprotein receptor
multiple interactions
EXP
geldanamycin inhibits the reaction [IL1B protein results in decreased expression of VLDLR protein]
CTD
PMID:15808840
NCBI chr 1:224,813,539...224,850,400
Ensembl chr 1:224,814,377...224,845,920
G
Vmp1
vacuole membrane protein 1
increases expression
ISO
geldanamycin results in increased expression of VMP1 mRNA
CTD
PMID:26705709
NCBI chr10:71,405,058...71,505,045
Ensembl chr10:71,405,452...71,505,007
G
Vps50
VPS50 subunit of EARP/GARPII complex
increases expression
ISO
geldanamycin results in increased expression of VPS50 mRNA
CTD
PMID:26705709
NCBI chr 4:31,484,424...31,585,617
Ensembl chr 4:31,484,463...31,585,617
G
Zbed6
zinc finger, BED-type containing 6
increases expression
ISO
geldanamycin results in increased expression of ZBED6 mRNA
CTD
PMID:26705709
NCBI chr13:45,107,253...45,113,524
Ensembl chr13:45,071,718...45,114,009
G
Zc3h11a
zinc finger CCCH-type containing 11A
increases expression
ISO
geldanamycin results in increased expression of ZC3H11A mRNA
CTD
PMID:26705709
NCBI chr13:45,073,422...45,113,901
Ensembl chr13:45,071,718...45,114,009
G
Zfhx4
zinc finger homeobox 4
increases expression
ISO
geldanamycin results in increased expression of ZFHX4 mRNA
CTD
PMID:26705709
NCBI chr 2:96,224,763...96,408,245
Ensembl chr 2:96,224,767...96,408,228
G
Zfp207
zinc finger protein 207
decreases expression
ISO
geldanamycin results in decreased expression of ZNF207 mRNA
CTD
PMID:30166341
NCBI chr10:65,385,807...65,398,086
Ensembl chr10:65,385,740...65,397,386
G
Zfp326
zinc finger protein 326
increases expression
ISO
geldanamycin results in increased expression of ZNF326 mRNA
CTD
PMID:26705709
NCBI chr14:3,941,210...3,980,419
Ensembl chr14:3,941,958...3,980,384
G
Zfp518a
zinc finger protein 518A
increases expression
ISO
geldanamycin results in increased expression of ZNF518A mRNA
CTD
PMID:26705709
NCBI chr 1:239,719,305...239,744,978
Ensembl chr 1:239,719,505...239,744,979
G
Zfp638
zinc finger protein 638
increases expression
ISO
geldanamycin results in increased expression of ZNF638 mRNA
CTD
PMID:26705709
NCBI chr 4:116,355,934...116,475,051
Ensembl chr 4:116,402,428...116,479,845
G
Zfp655
zinc finger protein 655
increases expression
ISO
geldanamycin results in increased expression of ZNF655 mRNA
CTD
PMID:26705709
NCBI chr12:9,349,985...9,375,449
Ensembl chr12:9,357,639...9,374,569
G
Zfp704
zinc finger protein 704
increases expression
ISO
geldanamycin results in increased expression of ZNF704 mRNA
CTD
PMID:26705709
NCBI chr 2:92,171,804...92,356,059
Ensembl chr 2:92,171,496...92,351,282
G
Zfp711
zinc finger protein 711
increases expression
ISO
geldanamycin results in increased expression of ZNF711 mRNA
CTD
PMID:26705709
NCBI chr X:77,646,300...77,679,398
Ensembl chr X:77,646,558...77,678,045
G
Zfp770
zinc finger protein 770
increases expression
ISO
geldanamycin results in increased expression of ZNF770 mRNA
CTD
PMID:26705709
NCBI chr 3:100,963,430...100,971,663
Ensembl chr 3:100,963,427...100,971,684
G
Zfr
zinc finger RNA binding protein
increases expression
ISO
geldanamycin results in increased expression of ZFR mRNA
CTD
PMID:26705709
NCBI chr 2:61,137,611...61,200,322
Ensembl chr 2:61,137,611...61,200,322
G
Zfx
zinc finger protein X-linked
increases expression
ISO
geldanamycin results in increased expression of ZFX mRNA
CTD
PMID:26705709
NCBI chr X:58,804,690...58,853,155
Ensembl chr X:58,804,691...58,853,265
G
Zmynd11
zinc finger, MYND-type containing 11
increases expression
ISO
geldanamycin results in increased expression of ZMYND11 mRNA
CTD
PMID:26705709
NCBI chr17:60,542,669...60,631,913
Ensembl chr17:60,543,077...60,631,902
G
Znf660
zinc finger protein 660
increases expression
ISO
geldanamycin results in increased expression of ZNF660 mRNA
CTD
PMID:26705709
NCBI chr 8:122,523,881...122,537,581
Ensembl chr 8:122,524,324...122,536,247
G
Zxdc
ZXD family zinc finger C
increases expression
ISO
geldanamycin results in increased expression of ZXDC mRNA
CTD
PMID:26705709
NCBI chr 4:122,882,389...122,914,486
Ensembl chr 4:122,882,336...122,916,496
G
Abhd11
abhydrolase domain containing 11
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of ABHD11 protein
CTD
PMID:31370342
NCBI chr12:21,682,206...21,685,331
Ensembl chr12:21,682,202...21,685,398
G
Actr1a
actin related protein 1A
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of ACTR1A protein
CTD
PMID:31370342
NCBI chr 1:245,237,821...245,256,618
Ensembl chr 1:245,237,826...245,256,495
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
increases expression
ISO
tanespimycin results in increased expression of ADAMTS1 mRNA
CTD
PMID:19514085
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
G
Agr2
anterior gradient 2, protein disulphide isomerase family member
multiple interactions increases expression
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of AGR2 protein tanespimycin analog results in increased expression of AGR2 protein; tanespimycin results in increased expression of AGR2 protein
CTD
PMID:31370342
NCBI chr 6:52,708,602...52,729,378
Ensembl chr 6:52,708,602...52,729,371
G
Ahr
aryl hydrocarbon receptor
multiple interactions decreases expression
ISO
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [tanespimycin results in decreased expression of AHR protein]
CTD
PMID:37217010
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Ak9
adenylate kinase 9
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of AK9 protein
CTD
PMID:31370342
NCBI chr20:44,724,494...44,941,135
Ensembl chr20:44,724,496...44,941,136
G
Akt1
AKT serine/threonine kinase 1
multiple interactions decreases expression affects expression
ISO EXP
Arsenic Trioxide promotes the reaction [tanespimycin results in decreased expression of AKT1 protein]; tanespimycin affects the reaction [Cannabidiol affects the expression of AKT1 protein]; tanespimycin promotes the reaction [Arsenic Trioxide results in decreased expression of AKT1 protein]; tanespimycin results in decreased expression of and results in decreased phosphorylation of AKT1 protein tanespimycin affects the expression of AKT1 protein
CTD
PMID:16923571 PMID:17157164 PMID:18566239 PMID:22810956 PMID:26504004
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Alb
albumin
affects binding multiple interactions
ISO
ALB protein binds to tanespimycin ALB protein inhibits the reaction [Copper results in increased oxidation of tanespimycin analog]
CTD
PMID:18393300
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of ALDH1A1 protein
CTD
PMID:31370342
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Alk
ALK receptor tyrosine kinase
decreases activity decreases expression
ISO
tanespimycin results in decreased activity of ALK protein mutant form tanespimycin results in decreased expression of ALK protein; tanespimycin results in decreased expression of ALK protein modified form
CTD
PMID:21030459 PMID:21502504
NCBI chr 6:22,879,653...23,599,636
Ensembl chr 6:22,880,625...23,598,034
G
Anxa1
annexin A1
increases expression
ISO
tanespimycin results in increased expression of ANXA1 protein
CTD
PMID:31370342
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Apaf1
apoptotic peptidase activating factor 1
multiple interactions increases expression
ISO
Scorpion Venoms results in increased susceptibility to [tanespimycin results in increased expression of APAF1 protein]
CTD
PMID:19913524
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
G
Ar
androgen receptor
decreases expression
ISO
tanespimycin results in decreased expression of AR protein
CTD
PMID:17010675
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Atp5f1a
ATP synthase F1 subunit alpha
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of ATP5F1A protein
CTD
PMID:31370342
NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794
G
Atp5f1b
ATP synthase F1 subunit beta
decreases expression
ISO
tanespimycin analog results in decreased expression of ATP5F1B protein
CTD
PMID:31370342
NCBI chr 7:515,454...521,858
Ensembl chr 7:515,460...567,273
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
tanespimycin results in decreased expression of BCL2 protein
CTD
PMID:16923571 PMID:28673683
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
decreases expression
ISO
tanespimycin results in decreased expression of BCL2L1 protein
CTD
PMID:16923571
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Bcl2l11
Bcl2-like 11
increases expression
ISO
tanespimycin results in increased expression of BCL2L11 protein
CTD
PMID:24784839
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
increases expression decreases expression
ISO EXP
tanespimycin analog results in increased expression of BRAF protein tanespimycin results in decreased expression of BRAF protein
CTD
PMID:22810956 PMID:31370342
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
G
Casp3
caspase 3
multiple interactions increases activity increases cleavage
ISO EXP
[tanespimycin co-treated with TNFSF10 protein] results in increased activity of CASP3 protein; Scorpion Venoms results in increased susceptibility to [tanespimycin results in increased activity of CASP3 protein]; tanespimycin results in increased cleavage of and results in increased activity of CASP3 protein SH-6 compound promotes the reaction [tanespimycin promotes the reaction [Dopamine results in increased activity of CASP3 protein]]; tanespimycin promotes the reaction [Dopamine results in increased activity of CASP3 protein] tanespimycin results in increased cleavage of CASP3 protein
CTD
PMID:15993848 PMID:17157164 PMID:18194434 PMID:19913524 PMID:22810956 PMID:24189122 More...
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
increases cleavage multiple interactions
ISO
tanespimycin results in increased cleavage of CASP8 protein [tanespimycin co-treated with Sirolimus] results in increased cleavage of CASP8 protein
CTD
PMID:17121904
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
multiple interactions increases cleavage
ISO
[tanespimycin co-treated with Sirolimus] results in increased cleavage of CASP9 protein tanespimycin results in increased cleavage of CASP9 protein
CTD
PMID:17121904
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccnd1
cyclin D1
decreases expression multiple interactions
ISO
tanespimycin results in decreased expression of CCND1 protein [Sirolimus co-treated with tanespimycin] results in decreased expression of CCND1 protein
CTD
PMID:17121904 PMID:17157164
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Cct8
chaperonin containing TCP1 subunit 8
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of CCT8 protein
CTD
PMID:31370342
NCBI chr11:26,710,370...26,722,079
Ensembl chr11:26,710,370...26,722,079
G
Cdc25c
cell division cycle 25C
multiple interactions decreases expression
ISO EXP
[tanespimycin co-treated with NQO1 protein] results in decreased expression of CDC25C protein tanespimycin results in decreased expression of CDC25C protein
CTD
PMID:21156818 PMID:22810956
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
G
Cdk1
cyclin-dependent kinase 1
multiple interactions decreases expression affects expression
ISO
[tanespimycin co-treated with NQO1 protein] results in decreased expression of CDK1 protein; tanespimycin affects the reaction [Cannabidiol affects the expression of CDK1 protein] tanespimycin results in decreased expression of CDK1 protein tanespimycin affects the expression of CDK1 protein
CTD
PMID:21156818 PMID:24784839 PMID:26504004
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
Cdk4
cyclin-dependent kinase 4
decreases expression
ISO
tanespimycin results in decreased expression of CDK4 protein
CTD
PMID:17157164 PMID:28673683 PMID:34291863
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
G
Cdk8
cyclin-dependent kinase 8
decreases expression
ISO
tanespimycin results in decreased expression of CDK8 protein
CTD
PMID:17157164
NCBI chr12:8,737,198...8,805,026
Ensembl chr12:8,737,262...8,804,177
G
Cebpb
CCAAT/enhancer binding protein beta
decreases expression
ISO
tanespimycin results in decreased expression of CEBPB protein
CTD
PMID:33609515
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
G
Ces1d
carboxylesterase 1D
increases expression
ISO
tanespimycin analog results in increased expression of CES1 protein
CTD
PMID:31370342
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
G
Chp2
calcineurin-like EF hand protein 2
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of CHP2 protein
CTD
PMID:31370342
NCBI chr 1:176,757,945...176,772,443
Ensembl chr 1:176,757,876...176,772,139
G
Commd1
copper metabolism domain containing 1
multiple interactions
ISO
tanespimycin promotes the reaction [COMMD1 protein results in increased degradation of HIF1A protein]
CTD
PMID:19802386
NCBI chr14:96,880,463...96,984,494
Ensembl chr14:96,880,463...96,984,501
G
Csde1
cold shock domain containing E1
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of CSDE1 protein
CTD
PMID:31370342
NCBI chr 2:190,546,015...190,582,787
Ensembl chr 2:190,554,980...190,582,784
G
Cttn
cortactin
multiple interactions increases expression
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of CTTN protein tanespimycin analog results in increased expression of CTTN protein
CTD
PMID:31370342
NCBI chr 1:199,599,710...199,635,254
Ensembl chr 1:199,599,710...199,635,164
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
affects metabolic processing
ISO
CYP3A5 protein affects the metabolism of tanespimycin
CTD
PMID:15718306
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Dars1
aspartyl-tRNA synthetase 1
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of DARS1 protein
CTD
PMID:31370342
NCBI chr13:39,857,936...39,913,055
Ensembl chr13:39,857,936...39,913,116
G
Dhrs2
dehydrogenase/reductase 2
increases expression
ISO
tanespimycin results in increased expression of DHRS2 protein
CTD
PMID:31370342
NCBI chr15:28,688,881...28,703,646
Ensembl chr15:28,688,940...28,703,644
G
Ebf2
EBF transcription factor 2
increases expression
ISO
tanespimycin analog results in increased expression of EBF2 protein
CTD
PMID:31370342
NCBI chr15:41,435,509...41,634,403
Ensembl chr15:41,435,509...41,634,403
G
Echdc3
enoyl CoA hydratase domain containing 3
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of ECHDC3 protein
CTD
PMID:31370342
NCBI chr17:72,070,697...72,093,519
Ensembl chr17:72,070,668...72,093,516
G
Eef1g
eukaryotic translation elongation factor 1 gamma
multiple interactions decreases expression
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of EEF1G protein tanespimycin analog results in decreased expression of EEF1G protein
CTD
PMID:31370342
NCBI chr 1:205,860,713...205,871,319
Ensembl chr 1:205,860,698...205,872,382
G
Eef2
eukaryotic translation elongation factor 2
increases expression multiple interactions
ISO
tanespimycin analog results in increased expression of EEF2 protein; tanespimycin results in increased expression of EEF2 protein [tanespimycin co-treated with VER 155008] results in increased expression of EEF2 protein
CTD
PMID:31370342
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
G
Egfr
epidermal growth factor receptor
decreases expression multiple interactions
ISO
tanespimycin analog results in decreased expression of EGFR protein; tanespimycin results in decreased expression of EGFR protein tanespimycin results in increased degradation of and results in decreased expression of EGFR protein
CTD
PMID:16061882 PMID:17010675 PMID:22810956 PMID:31370342
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Eif3i
eukaryotic translation initiation factor 3, subunit I
decreases expression multiple interactions
ISO
tanespimycin results in decreased expression of EIF3I protein [tanespimycin co-treated with VER 155008] results in decreased expression of EIF3I protein
CTD
PMID:31370342
NCBI chr 5:141,935,135...141,942,589
Ensembl chr 5:141,935,044...141,942,676
G
Eif4b
eukaryotic translation initiation factor 4B
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of EIF4B protein
CTD
PMID:31370342
NCBI chr 7:133,206,637...133,228,436
G
Eif4h
eukaryotic translation initiation factor 4H
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of EIF4H protein
CTD
PMID:31370342
NCBI chr12:22,083,155...22,099,876
Ensembl chr12:22,082,835...22,099,876
G
Eml5
EMAP like 5
multiple interactions increases expression
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of EML5 protein tanespimycin analog results in increased expression of EML5 protein
CTD
PMID:31370342
NCBI chr 6:118,046,655...118,175,831
Ensembl chr 6:118,046,655...118,175,831
G
Eno1
enolase 1
increases expression
ISO
tanespimycin analog results in increased expression of ENO1 protein
CTD
PMID:31370342
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
G
Erbb2
erb-b2 receptor tyrosine kinase 2
multiple interactions decreases expression
ISO
tanespimycin results in increased degradation of and results in decreased expression of ERBB2 protein tanespimycin results in decreased expression of ERBB2 protein
CTD
PMID:16061882 PMID:24784839 PMID:34291863
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
G
Eri1
exoribonuclease 1
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of ERI1 protein
CTD
PMID:31370342
NCBI chr16:56,724,101...56,744,228
Ensembl chr16:56,724,115...56,744,226
G
Erp29
endoplasmic reticulum protein 29
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of ERP29 protein
CTD
PMID:31370342
NCBI chr12:35,089,698...35,095,952
Ensembl chr12:35,089,707...35,096,376
G
Farsb
phenylalanyl-tRNA synthetase subunit beta
multiple interactions increases expression
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of FARSB protein tanespimycin analog results in increased expression of FARSB protein; tanespimycin results in increased expression of FARSB protein
CTD
PMID:31370342
NCBI chr 9:79,887,852...79,947,082
Ensembl chr 9:79,887,842...79,947,045
G
Fgf1
fibroblast growth factor 1
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of FGF1 protein
CTD
PMID:31370342
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
G
Fgfr3
fibroblast growth factor receptor 3
multiple interactions
ISO
tanespimycin results in increased degradation of and results in decreased expression of FGFR3 protein
CTD
PMID:16061882
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
G
Flt3
Fms related receptor tyrosine kinase 3
decreases expression
ISO
tanespimycin results in decreased expression of FLT3 protein
CTD
PMID:17010675
NCBI chr12:7,623,930...7,699,474
Ensembl chr12:7,623,930...7,699,474
G
Fubp1
far upstream element binding protein 1
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of FUBP1 protein
CTD
PMID:31370342
NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
G
Gcfc2
GC-rich sequence DNA-binding factor 2
increases expression
ISO
tanespimycin analog results in increased expression of GCFC2 protein
CTD
PMID:31370342
NCBI chr 4:114,481,613...114,519,268
Ensembl chr 4:114,481,607...114,519,962
G
Gls
glutaminase
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of GLS protein
CTD
PMID:31370342
NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900
G
Gsk3b
glycogen synthase kinase 3 beta
decreases expression
ISO
tanespimycin results in decreased expression of GSK3B protein modified form
CTD
PMID:20090934
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Gtf2a2
general transcription factor 2A subunit 2
increases expression
ISO
tanespimycin analog results in increased expression of GTF2A2 protein
CTD
PMID:31370342
NCBI chr 8:70,662,447...70,675,576
Ensembl chr 8:70,662,428...70,675,569
G
Gtf2ird1
GTF2I repeat domain containing 1
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of GTF2IRD1 protein
CTD
PMID:31370342
NCBI chr12:22,254,113...22,361,052
Ensembl chr12:22,254,221...22,361,040
G
Hif1a
hypoxia inducible factor 1 subunit alpha
multiple interactions
ISO
tanespimycin promotes the reaction [COMMD1 protein results in increased degradation of HIF1A protein]
CTD
PMID:19802386
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hint1
histidine triad nucleotide binding protein 1
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of HINT1 protein
CTD
PMID:31370342
NCBI chr10:38,989,516...38,993,259
Ensembl chr 4:92,100,973...92,101,568
G
Hsd17b10
hydroxysteroid (17-beta) dehydrogenase 10
decreases expression multiple interactions
ISO
tanespimycin analog results in decreased expression of HSD17B10 protein; tanespimycin results in decreased expression of HSD17B10 protein [tanespimycin co-treated with VER 155008] results in decreased expression of HSD17B10 protein
CTD
PMID:31370342
NCBI chr X:21,089,142...21,091,603
Ensembl chr X:21,089,122...21,109,488
G
Hsf1
heat shock transcription factor 1
affects localization multiple interactions increases activity
ISO
tanespimycin affects the localization of HSF1 protein [tanespimycin affects the localization of HSF1 protein] which results in increased expression of HSPA1A protein tanespimycin results in increased activity of HSF1 protein
CTD
PMID:20090934 PMID:34170685
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
multiple interactions decreases expression affects binding
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of HSP90AA1 protein; N-(5-methylisoxazol-3-yl)-2-(4-(thiophen-2-yl)-6-(trifluoromethyl)pyrimidin-2-ylthio)acetamide inhibits the reaction [tanespimycin binds to HSP90AA1 protein] tanespimycin results in decreased expression of HSP90AA1 protein
CTD
PMID:18830594 PMID:22895790 PMID:31370342
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
G
Hsp90ab1
heat shock protein 90 alpha family class B member 1
affects binding
ISO
tanespimycin binds to HSP90AB1 protein
CTD
PMID:22895790
NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
multiple interactions increases expression
ISO
[tanespimycin affects the localization of HSF1 protein] which results in increased expression of HSPA1A protein tanespimycin analog results in increased expression of HSPA1A protein
CTD
PMID:20090934 PMID:31370342
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of HSPA1B protein
CTD
PMID:31370342
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspa4
heat shock protein family A (Hsp70) member 4
increases expression multiple interactions
ISO
tanespimycin results in increased expression of HSPA4 protein [tanespimycin results in increased expression of HSPA4 protein] which results in decreased susceptibility to Doxorubicin
CTD
PMID:16311509
NCBI chr10:37,408,025...37,449,080
Ensembl chr10:37,408,025...37,449,001
G
Hspa5
heat shock protein family A (Hsp70) member 5
increases expression
ISO
tanespimycin results in increased expression of HSPA5 protein
CTD
PMID:16357177
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of HSPA6 protein
CTD
PMID:31370342
NCBI chr13:83,273,176...83,274,317
G
Hspd1
heat shock protein family D (Hsp60) member 1
decreases expression multiple interactions
ISO
tanespimycin results in decreased expression of HSPD1 protein [tanespimycin co-treated with VER 155008] results in decreased expression of HSPD1 protein
CTD
PMID:23144451 PMID:31370342
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
G
Igf1r
insulin-like growth factor 1 receptor
affects expression decreases expression
ISO EXP
tanespimycin affects the expression of IGF1R protein tanespimycin results in decreased expression of IGF1R protein
CTD
PMID:22810956
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
G
Ilf3
interleukin enhancer binding factor 3
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of ILF3 protein
CTD
PMID:31370342
NCBI chr 8:19,922,409...19,960,495
Ensembl chr 8:19,922,460...19,960,350
G
Kcnv2
potassium voltage-gated channel modifier subfamily V member 2
decreases expression multiple interactions
ISO
tanespimycin analog results in decreased expression of KCNV2 protein [tanespimycin co-treated with VER 155008] results in decreased expression of KCNV2 protein
CTD
PMID:31370342
NCBI chr 1:224,999,552...225,014,062
Ensembl chr 1:224,999,552...225,014,062
G
Kdm3a
lysine demethylase 3A
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of KDM3A protein
CTD
PMID:31370342
NCBI chr 4:103,630,907...103,675,073
Ensembl chr 4:103,630,908...103,675,073
G
Kdr
kinase insert domain receptor
affects expression decreases expression
ISO EXP
tanespimycin affects the expression of KDR protein tanespimycin results in decreased expression of KDR protein
CTD
PMID:22810956
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Kit
KIT proto-oncogene receptor tyrosine kinase
decreases expression multiple interactions
ISO EXP
tanespimycin results in decreased expression of KIT protein tanespimycin results in increased degradation of and results in decreased expression of KIT protein
CTD
PMID:16061882 PMID:16213582 PMID:22810956
NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
G
Larp7
La ribonucleoprotein 7, transcriptional regulator
increases expression
ISO
tanespimycin analog results in increased expression of LARP7 protein
CTD
PMID:31370342
NCBI chr 2:215,997,641...216,012,833
Ensembl chr 2:215,997,649...216,012,865
G
Lcp1
lymphocyte cytosolic protein 1
increases expression multiple interactions
ISO
tanespimycin analog results in increased expression of LCP1 protein [tanespimycin co-treated with VER 155008] results in increased expression of LCP1 protein
CTD
PMID:31370342
NCBI chr15:50,443,300...50,544,682
Ensembl chr15:50,488,149...50,544,680
G
Ldha
lactate dehydrogenase A
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of LDHA protein
CTD
PMID:31370342
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
G
Ldhb
lactate dehydrogenase B
increases expression
ISO
tanespimycin analog results in increased expression of LDHB protein
CTD
PMID:31370342
NCBI chr 4:175,428,382...175,446,403
Ensembl chr 4:175,428,385...175,446,403
G
Lmna
lamin A/C
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of LMNA protein
CTD
PMID:31370342
NCBI chr 2:173,939,751...173,960,423
Ensembl chr 2:173,939,751...173,960,423
G
Lrpprc
leucine-rich pentatricopeptide repeat containing
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of LRPPRC protein
CTD
PMID:31370342
NCBI chr 6:9,859,816...9,942,294
Ensembl chr 6:9,859,867...9,942,293
G
Map2k6
mitogen-activated protein kinase kinase 6
multiple interactions
ISO
[salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP mRNA]; [salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP protein]
CTD
PMID:30796972
NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293
G
Mapk1
mitogen activated protein kinase 1
decreases phosphorylation multiple interactions affects expression
ISO EXP
tanespimycin results in decreased phosphorylation of MAPK1 protein tanespimycin results in increased expression of and results in decreased phosphorylation of MAPK1 protein tanespimycin affects the reaction [Cannabidiol affects the expression of MAPK1 protein] tanespimycin affects the expression of MAPK1 protein
CTD
PMID:17157164 PMID:20090934 PMID:21502504 PMID:22810956 PMID:24784839 PMID:26504004 More...
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
decreases phosphorylation multiple interactions affects expression
ISO EXP
tanespimycin results in decreased phosphorylation of MAPK3 protein tanespimycin results in increased expression of and results in decreased phosphorylation of MAPK3 protein tanespimycin affects the reaction [Cannabidiol affects the expression of MAPK3 protein] tanespimycin affects the expression of MAPK3 protein
CTD
PMID:17157164 PMID:20090934 PMID:21502504 PMID:22810956 PMID:24784839 PMID:26504004 More...
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
decreases expression
ISO
tanespimycin results in decreased expression of MCL1 protein
CTD
PMID:16923571
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
G
Mdm2
MDM2 proto-oncogene
increases degradation
ISO
tanespimycin results in increased degradation of MDM2 protein
CTD
PMID:17157164
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Met
MET proto-oncogene, receptor tyrosine kinase
decreases expression
EXP ISO
tanespimycin results in decreased expression of MET protein
CTD
PMID:22810956
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Mif
macrophage migration inhibitory factor
multiple interactions decreases expression
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of MIF protein tanespimycin results in decreased expression of MIF protein
CTD
PMID:31370342
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
G
Mllt10
MLLT10, histone lysine methyltransferase DOT1L cofactor
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of MLLT10 protein
CTD
PMID:31370342
NCBI chr17:80,821,870...80,949,349
Ensembl chr17:80,822,556...80,949,345
G
Mmp2
matrix metallopeptidase 2
multiple interactions
ISO
tanespimycin affects the reaction [Nickel results in increased activity of MMP2 protein]; tanespimycin inhibits the reaction [Nickel results in increased expression of MMP2 mRNA]
CTD
PMID:21401309
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
multiple interactions
ISO
tanespimycin affects the reaction [Nickel results in increased activity of MMP9 protein]; tanespimycin inhibits the reaction [Nickel results in increased expression of MMP9 mRNA]
CTD
PMID:21401309
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Msn
moesin
increases expression
ISO
tanespimycin analog results in increased expression of MSN protein
CTD
PMID:31370342
NCBI chr X:60,996,043...61,064,011
Ensembl chr X:60,995,951...61,065,628
G
Mtap
methylthioadenosine phosphorylase
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of MTAP protein
CTD
PMID:31370342
NCBI chr 5:103,874,460...103,920,684
Ensembl chr 5:103,873,020...103,939,406
G
Mtss1
MTSS I-BAR domain containing 1
increases expression
ISO
tanespimycin results in increased expression of MTSS1 mRNA
CTD
PMID:19514085
NCBI chr 7:90,488,751...90,628,007
Ensembl chr 7:90,488,754...90,627,968
G
Nampt
nicotinamide phosphoribosyltransferase
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of NAMPT protein
CTD
PMID:31370342
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
G
Nans
N-acetylneuraminate synthase
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of NANS protein
CTD
PMID:31370342
NCBI chr 5:60,780,441...60,797,583
Ensembl chr 5:60,780,392...60,814,950
G
Ncl
nucleolin
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of NCL protein
CTD
PMID:31370342
NCBI chr 9:86,999,588...87,008,112
Ensembl chr 9:86,998,019...87,008,136
G
Nfkbia
NFKB inhibitor alpha
increases expression decreases phosphorylation
EXP ISO
tanespimycin results in increased expression of NFKBIA protein tanespimycin results in decreased phosphorylation of NFKBIA protein
CTD
PMID:11835313 PMID:22810956
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
multiple interactions decreases expression
EXP
Quercetin inhibits the reaction [tanespimycin results in decreased expression of NOS2 mRNA]
CTD
PMID:11835313
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions increases abundance increases reduction increases response to substance
ISO
[5-methoxy-1,2-dimethyl-3-((4-nitrophenoxy)methyl)indole-4,7-dione results in decreased activity of NQO1 protein] which results in decreased abundance of tanespimycin; [5-methoxy-1,2-dimethyl-3-((4-nitrophenoxy)methyl)indole-4,7-dione results in decreased activity of NQO1 protein] which results in decreased abundance of tanespimycin metabolite; [5-methoxy-1,2-dimethyl-3-((4-nitrophenoxy)methyl)indole-4,7-dione results in decreased activity of NQO1 protein] which results in decreased susceptibility to tanespimycin; [NQO1 protein results in increased reduction of tanespimycin] which results in increased chemical synthesis of tanespimycin metabolite; [tanespimycin co-treated with NQO1 protein] results in decreased expression of CDC25C protein; [tanespimycin co-treated with NQO1 protein] results in decreased expression of CDK1 protein NQO1 protein results in increased abundance of tanespimycin; NQO1 protein results in increased abundance of tanespimycin metabolite NQO1 protein results in increased susceptibility to tanespimycin
CTD
PMID:10564678 PMID:21156818 PMID:24552538
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Oat
ornithine aminotransferase
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of OAT protein
CTD
PMID:31370342
NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682
G
Pa2g4
proliferation-associated 2G4
multiple interactions increases expression
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of PA2G4 protein tanespimycin analog results in increased expression of PA2G4 protein; tanespimycin results in increased expression of PA2G4 protein
CTD
PMID:31370342
NCBI chr 7:984,795...992,264
Ensembl chr 7:983,971...992,331
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
EXP ISO
tanespimycin results in increased cleavage of PARP1 protein
CTD
PMID:22810956
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Parp2
poly (ADP-ribose) polymerase 2
increases expression
ISO
tanespimycin analog results in increased expression of PARP2 protein
CTD
PMID:31370342
NCBI chr15:24,034,069...24,044,340
Ensembl chr15:24,034,106...24,044,338
G
Pdgfrb
platelet derived growth factor receptor beta
decreases expression
ISO EXP
tanespimycin results in decreased expression of PDGFRB protein
CTD
PMID:22810956
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
G
Pdia4
protein disulfide isomerase family A, member 4
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of PDIA4 protein
CTD
PMID:31370342
NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:76,803,198...76,822,107
G
Pfn1
profilin 1
increases expression
ISO
tanespimycin analog results in increased expression of PFN1 protein
CTD
PMID:31370342
NCBI chr10:55,365,263...55,367,968
Ensembl chr10:55,365,262...55,527,631
G
Pgr
progesterone receptor
decreases expression
ISO
tanespimycin results in decreased expression of PGR protein
CTD
PMID:11448926
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
G
Pip4k2c
phosphatidylinositol-5-phosphate 4-kinase type 2 gamma
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of PIP4K2C protein
CTD
PMID:31370342
NCBI chr 7:63,020,004...63,035,086
Ensembl chr 7:63,020,000...63,035,078
G
Pkm
pyruvate kinase M1/2
decreases expression
ISO
tanespimycin results in decreased expression of PKM protein
CTD
PMID:31370342
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
G
Pnn
pinin, desmosome associated protein
increases expression
ISO
tanespimycin results in increased expression of PNN mRNA
CTD
PMID:19514085
NCBI chr 6:76,758,138...76,766,451
Ensembl chr 6:76,758,117...76,766,889
G
Prkrip1
PRKR interacting protein 1
increases expression
ISO
tanespimycin analog results in increased expression of PRKRIP1 protein
CTD
PMID:31370342
NCBI chr12:20,470,802...20,491,789
Ensembl chr12:20,470,820...20,489,115
G
Prps2
phosphoribosyl pyrophosphate synthetase 2
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of PRPS2 protein
CTD
PMID:31370342
NCBI chr X:26,975,915...27,013,184
Ensembl chr X:26,976,061...27,013,181
G
Psma6
proteasome 20S subunit alpha 6
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of PSMA6 protein
CTD
PMID:31370342
NCBI chr 6:72,765,534...72,796,554
Ensembl chr 6:72,765,473...72,796,554
G
Psma7
proteasome 20S subunit alpha 7
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of PSMA7 protein
CTD
PMID:31370342
NCBI chr 3:167,137,279...167,143,626
Ensembl chr 3:167,137,263...167,143,672
G
Rab17
RAB17, member RAS oncogene family
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of RAB17 protein
CTD
PMID:31370342
NCBI chr 9:91,552,924...91,566,759
Ensembl chr 9:91,553,464...91,566,451
G
Raf1
Raf-1 proto-oncogene, serine/threonine kinase
decreases expression
ISO
tanespimycin results in decreased expression of RAF1 protein
CTD
PMID:10564678 PMID:34291863
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
G
Rb1
RB transcriptional corepressor 1
decreases phosphorylation multiple interactions
ISO
tanespimycin results in decreased phosphorylation of RB1 protein [tanespimycin co-treated with Sirolimus] results in decreased phosphorylation of RB1 protein
CTD
PMID:17121904
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rdx
radixin
increases expression multiple interactions
ISO
tanespimycin analog results in increased expression of RDX protein [tanespimycin co-treated with VER 155008] results in increased expression of RDX protein
CTD
PMID:31370342
NCBI chr 8:52,379,494...52,437,673
Ensembl chr 8:52,379,494...52,437,678
G
Rplp0
ribosomal protein lateral stalk subunit P0
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of RPLP0 protein
CTD
PMID:31370342
NCBI chr12:41,054,363...41,057,632
Ensembl chr12:41,054,179...41,057,632
G
Rps6
ribosomal protein S6
decreases phosphorylation decreases expression
ISO
tanespimycin results in decreased phosphorylation of RPS6 protein tanespimycin results in decreased expression of RPS6 protein
CTD
PMID:17121904 PMID:27255535
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
G
Runx1
RUNX family transcription factor 1
decreases expression
ISO
tanespimycin results in decreased expression of RUNX1 protein mutant form
CTD
PMID:33609515
NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542
G
Runx1t1
RUNX1 partner transcriptional co-repressor 1
decreases expression
ISO
tanespimycin results in decreased expression of RUNX1T1 protein mutant form
CTD
PMID:33609515
NCBI chr 5:27,187,674...27,338,070
Ensembl chr 5:27,187,551...27,335,592
G
Selenbp1
selenium binding protein 1
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of SELENBP1 protein
CTD
PMID:31370342
NCBI chr 2:182,494,004...182,504,594
Ensembl chr 2:182,493,978...182,504,594
G
Serpinb5
serpin family B member 5
increases expression
ISO
tanespimycin results in increased expression of SERPINB5 mRNA
CTD
PMID:19514085
NCBI chr13:22,985,557...23,005,756
Ensembl chr13:22,985,557...23,005,756
G
Shmt2
serine hydroxymethyltransferase 2
decreases expression
ISO
tanespimycin analog results in decreased expression of SHMT2 protein
CTD
PMID:31370342
NCBI chr 7:63,358,961...63,364,293
Ensembl chr 7:63,358,961...63,364,236
G
Sod2
superoxide dismutase 2
increases abundance increases response to substance
ISO
SOD2 protein results in increased abundance of tanespimycin metabolite SOD2 protein results in increased susceptibility to tanespimycin
CTD
PMID:21156818
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Srcin1
SRC kinase signaling inhibitor 1
increases expression multiple interactions
ISO
tanespimycin analog results in increased expression of SRCIN1 protein; tanespimycin results in increased expression of SRCIN1 protein [tanespimycin co-treated with VER 155008] results in increased expression of SRCIN1 protein
CTD
PMID:31370342
NCBI chr10:82,502,911...82,569,882
Ensembl chr10:82,504,393...82,571,040
G
Tagln2
transgelin 2
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of TAGLN2 protein
CTD
PMID:31370342
NCBI chr13:84,966,980...84,973,973
Ensembl chr13:84,967,009...84,973,972
G
Timp3
TIMP metallopeptidase inhibitor 3
increases expression
ISO
tanespimycin results in increased expression of TIMP3 mRNA
CTD
PMID:19514085
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
G
Tnfsf10
TNF superfamily member 10
multiple interactions
ISO
[tanespimycin co-treated with TNFSF10 protein] results in decreased expression of XIAP protein; [tanespimycin co-treated with TNFSF10 protein] results in increased activity of CASP3 protein
CTD
PMID:15993848
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tp53
tumor protein p53
decreases expression
ISO
tanespimycin results in decreased expression of TP53 protein
CTD
PMID:10564678
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tpte2
transmembrane phosphoinositide 3-phosphatase and tensin homolog 2
increases expression
ISO
tanespimycin analog results in increased expression of TPTE2 protein
CTD
PMID:31370342
NCBI chr16:69,658,874...69,756,571
Ensembl chr16:69,658,875...69,752,949
G
Tymp
thymidine phosphorylase
decreases expression multiple interactions
ISO
tanespimycin results in decreased expression of TYMP mRNA; tanespimycin results in decreased expression of TYMP protein [salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP mRNA]; [salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP protein]; [tanespimycin co-treated with salinomycin] results in decreased expression of TYMP mRNA; acetylleucyl-leucyl-norleucinal inhibits the reaction [tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP protein]]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP protein]]; SB 203580 promotes the reaction [[tanespimycin co-treated with salinomycin] results in decreased expression of TYMP mRNA]; tanespimycin inhibits the reaction [Dactinomycin promotes the reaction [salinomycin results in increased expression of TYMP mRNA]]; tanespimycin inhibits the reaction [salinomycin inhibits the reaction [Cycloheximide results in decreased expression of TYMP protein]]; tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP mRNA]; tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP protein]
CTD
PMID:30796972
NCBI chr 7:120,438,768...120,444,088
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
G
Tyms
thymidylate synthetase
decreases expression
ISO
tanespimycin results in decreased expression of TYMS protein
CTD
PMID:18830594
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
Ugdh
UDP-glucose 6-dehydrogenase
increases expression
ISO
tanespimycin analog results in increased expression of UGDH protein; tanespimycin results in increased expression of UGDH protein
CTD
PMID:31370342
NCBI chr14:42,848,704...42,872,351
Ensembl chr14:42,848,854...42,872,354
G
Ugp2
UDP-glucose pyrophosphorylase 2
decreases expression
ISO
tanespimycin results in decreased expression of UGP2 protein
CTD
PMID:31370342
NCBI chr14:95,456,330...95,497,483
Ensembl chr14:95,456,330...95,496,830
G
Vil1
villin 1
increases expression
ISO
tanespimycin analog results in increased expression of VIL1 protein
CTD
PMID:31370342
NCBI chr 9:75,991,141...76,018,860
Ensembl chr 9:75,991,141...76,018,858
G
Xiap
X-linked inhibitor of apoptosis
multiple interactions
ISO
[tanespimycin co-treated with TNFSF10 protein] results in decreased expression of XIAP protein
CTD
PMID:15993848
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
G
Yars1
tyrosyl-tRNA synthetase 1
multiple interactions
ISO
[tanespimycin co-treated with VER 155008] results in decreased expression of YARS1 protein
CTD
PMID:31370342
NCBI chr 5:141,535,815...141,564,029
Ensembl chr 5:141,535,759...141,563,833
G
Zyg11b
zyg-11 family member B, cell cycle regulator
multiple interactions increases expression
ISO
[tanespimycin co-treated with VER 155008] results in increased expression of ZYG11B protein tanespimycin analog results in increased expression of ZYG11B protein
CTD
PMID:31370342
NCBI chr 5:122,985,548...123,042,735
Ensembl chr 5:122,992,147...123,042,736
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all